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Background: Many patients eligible for bariatric surgery in Australia do not have 
private health insurance, which creates significant pressure on the public system, with 
prolonged wait-list times. Public hospital service use by this patient group is under-
investigated. Australia-wide, public hospitals perform a higher proportion of revisional 
procedures than private hospitals (36% vs 25%), possibly limiting access to primary 
procedures. The aim of the study was to investigate the impact of bariatric surgery provision 
in the Tasmanian public sector on public hospital service use, particularly hospital admissions 
and emergency department (ED) presentation rates and to identify and describe revisional 
surgery pathways, including subsequent re-revisions. 
Methods: A statewide retrospective cohort study was conducted of public hospital 
service use by all Tasmanian patients on the wait-list for publicly funded bariatric surgery from 
2008 to 2013. Multiple administrative databases and data linked with the Tasmanian Death 
Registry were used.  
Rates of hospital admissions in 2006–2014 and ED presentations in 2000–2014 were 
compared for operated-on patients and those who dropped-out of the wait-list. Public hospital 
service use was analysed in different periods: prior to wait-list placement, while on the wait-
list, and after removal from the wait-list either after having a bariatric procedure or dropping 
out without surgery. Incidence rate ratios (IRR) with 95% confidence intervals (CI) for groups 
and periods comparisons were derived using a negative binomial regression mixed-effects 
model adjusted for sex, age and non-independent observation periods. 
Hospital service use was analysed for primary vs revisional bariatric surgery recipients 
using similar methods. 
Abstract 
XIX 
A systematic review of revisional surgery outcomes, such as subsequent revisions and 
complication rates, was performed, including papers following at least 75% of patients for 12 
months or more. 
Results: The cohort study identified 652 patients wait-listed for primary bariatric 
surgery, of whom 178 (27.3%) had bariatric surgery and 236 (36.2%) dropped-out from the 
wait-list. Together, these patients had 3,120 public hospital admissions and 5,149 ED 
presentations. Number of days in hospital per year was higher for the dropped-out patients than 
for surgery recipients while on the wait-list (IRR 2.22, 95% CI 1.36–3.61). Hospital admission 
rates did not increase post-surgery (IRR 1.08, 95% CI 0.83–1.41) but days admitted per year 
did increase (IRR 1.53, 95% CI 1.01–2.34). ED presentation rates did not change significantly 
post-surgery compared with the waiting period (IRR 1.19, 95% CI 0.90–1.56). Presentation 
rates significantly increased for digestive system (IRR 2.02, 95% CI 1.19–3.45) and psychiatric 
diseases (IRR 4.85, 95% CI 1.06–22.26) after surgery. The likelihood of being admitted from 
the ED significantly increased after surgery (31.7% to 38.9%, p<0.05). 
A total of 95 patients wait-listed for revisional surgery were identified; 91 (95.2%) of 
the patients were operated-on as planned, and two more had emergency surgeries after removal 
from the wait-list. Including subsequent planned and emergency revisions, of the 320 bariatric 
procedures performed with public funding for patients while wait-listed for bariatric surgery in 
2008–2013, 142 (44.8%) were performed for revisional surgery. The mean primary surgery 
wait-list time was significantly (p<0.05) longer than for revisional surgery: 4.1±2.8 vs 0.8±1.0 
years, respectively. Compared with primary-only surgery recipients, revisional surgery 
recipients had higher public hospital admission rates (IRR 2.60, 95% CI 1.63–4.13 while on 
wait-list and IRR 1.98, 95% CI 1.31–2.98 post-surgery); more days in hospital per year (IRR 
2.68, 95% CI 1.44–4.99 while on wait-list and IRR 2.10, 95% CI 1.18–3.76 post-surgery); and 
higher ED presentation rates after the surgery (IRR 1.76, 95% CI 1.15–2.70). 
Abstract 
XX 
For the systematic review, the search identified 28 papers (1317 patients with surgical 
revisions) following at least 75% of patients for 12 months or more. For adjustable gastric 
banding (AGB), rebanding had higher re-revisional rates than conversions into other 
procedures. Conversion of AGB to Roux-en-Y gastric by-pass had the highest number of short-
term (10.7%) and long-term (22.0%) complications. We estimated 8.8% of patients required 
tertiary surgery, with 194 reoperations (tertiary, subsequent and for complications) per 1000 
patients undergoing a secondary procedure. 
Conclusion: Bariatric surgery performed in the public hospital setting in Tasmania was 
followed by an increase in hospital service use. Revisions represented nearly half of the public 
bariatric surgery procedures in Tasmania and were higher priorities. Revisional surgery in the 
public system, including revisions for primary surgery performed in the private system, limits 
access to public primary surgery. Future planning for bariatric surgery in the public sector 
should account for the increase in public hospital service use and demand for revisions, 
including tertiary and subsequent revisions and their long-term complications. 
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Chapter 1: Introduction 
1.1 Obesity as a problem 
1.1.1 Definition of obesity 
Obesity is defined by the World Health Organization (WHO) as a disease in which 
excess body fat has accumulated to such an extent that health may be adversely affected; 
however, the amount of excess fat, its distribution within the body, and the associated health 
consequences vary considerably among obese individuals [1]. This definition goes beyond the 
initial straightforward definitions by WHO, the Obesity Society (USA) with collaborators and 
the National Health and Medical Research Council (Australia) of obesity as a body mass index 
(BMI) over 30 kg/m2 and overweight as BMI over 25 and less than 30 kg/m2 [2, 3]. BMI is 
determined by measuring a person’s weight and height and dividing weight in kilograms by 
height in metres squared. Obesity is divided into three classes (or grades): Class I with BMI 
30.0–34.9 kg/m2, Class II with BMI 35.0–34.9 kg/m2, and Class III with BMI ≥40.0 kg/m2 and 
more. When first introduced, this classification did not have any clinical or policy implications 
[4]. 
However, BMI-based classifications are used in the diagnosis of obesity as the simplest 
method, despite being only a surrogate measure and not providing an accurate representation 
of body fat composition [5]. BMI does not discriminate between lean and fat mass and does 
not take whole body fat distribution into consideration, therefore leaving a possibility of 
misclassification of persons of short stature or muscular build as overweight or obese [6] or 
underestimation of obesity among those with normal or overweight BMI but a body fat 
percentage within the obesity range according to the cut-offs for body fat percentage most 
commonly reported in the literature [7]. The BMI continuum should also be adjusted for the 
Asian population, which has different associations among BMI, body fat percentage and 
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obesity health risks and comorbidities, compared to the European population for whom the 
guidelines and classifications were initially developed [8]. In addition, Polynesians have 
significantly higher ratio of lean to fat mass compared with Europeans, and for this population 
BMI thresholds should be increased [9, 10]. Moreover, these classifications do not include a 
direct assessment of comorbidities related to obesity or functional status [11].  
1.1.2 Epidemiology of obesity 
The prevalence of obesity worldwide has often been referred to as a pandemic with 
trends of increasing obesity in many countries [12, 13]. A global systematic analysis revealed 
that the prevalence of overweight and obesity between 1980 and 2013 increased by 27.5% for 
adults and 47.1% for children, with absolute numbers rising from 921 million to 2.1 billion 
[14]. This report found increases in both developed and developing countries for all sexes and 
ages, although in different proportions. There are certain regions with an estimated prevalence 
of obesity in over 50% of females (Kuwait, Kiribati, Micronesia, Libya, Qatar, Tonga, and 
Samoa) and males (Tonga). The estimated number of persons with obesity according to this 
report is 693 million, with more than 50% of those living in only 10 countries: USA, China, 
India, Russia, Brazil, Mexico, Egypt, Pakistan, Indonesia, and Germany. Despite the high 
absolute numbers of obese individuals in India and China, the prevalence of obesity there is 
relatively low (less than 5%). The report did not find any country with a significant decline in 
obesity rates within the 33-year period, suggesting that obesity rates will continue to increase, 
especially in developing counties. 
According to the National Health Survey 2014–15 by the Australian Bureau of 
Statistics, 11.2 million (63.4%) Australians aged 18 and over were overweight or obese, with 
6.3 million (35.5%) overweight and 4.9 million (27.9%) obese [15]. While the survey noted 
the increasing prevalence of overweight and obesity between 1995 and 2012 from 56.3% to 
62.8%, the trend appeared to stabilise from 2012 to 2015. The prevalence of overweight and 
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obesity is higher in Australian males (70.8%) than in females (56.3%). However, advanced 
obesity (Class 2 and Class 3) is more prevalent among Australian females than males (10.7% 
vs 8.0%) [16] (Figure 1). Obesity is more prevalent in Australians living in regional and remote 
areas compared with those in major cities. Females living in areas of socio-economic 
disadvantage are more likely to be overweight or obese than females in less disadvantaged 
areas, with no difference for males. 
 
Figure 1. Distribution of body mass index in adults by sex, 2014–15 (reproduced from the 
Australian Institute of Health and Welfare, 2017 [16]) 
In Tasmania, the estimated prevalence of obesity is higher than the national average, 
with 68% of individuals overweight or obese, including 74% of men and 61% of women 
(Figure 2) [17].  
1.1.3 Comorbidities of obesity 
Obesity is associated with a number of medical conditions, including hypothyroidism, 
Cushing’s syndrome, and polycystic ovary syndrome and is also an established risk factor for 
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the development of a wide range of comorbidities, such as dyslipidaemia, type 2 diabetes, 
hypertension, coronary heart disease, stroke, obstructive sleep apnoea, osteoarthritis, and a 
number of cancers [18]. 
 
Figure 2. Body mass index, estimated proportion (%) of persons in Tasmania (adapted from 
the National Health Survey 2014–15 [17]). 
Excess weight is a well-established risk factor for the development of type 2 diabetes, 
although the majority of obese people do not develop the disease [19]. Compared with normal 
weight adults, individuals with a BMI over 40 kg/m2 have an odds ratio of 7.4 for a diagnosis 
of diabetes [20]. The risk of type 2 diabetes increases not only with increased body mass but 
also with increased adiposity of the upper body, as indicated by an increased waist-to-hip ratio 
[21]. At least three possible mechanisms have been suggested to link the predisposition of 
patients with obesity to type 2 diabetes through decreased insulin sensitivity: increased 
production of adipokines/cytokines (including tumour necrosis factor and interleukin-6), 
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Similar mechanisms also contribute to the development of cardiovascular diseases, 
making obesity an important cardiovascular risk factor [25]. In large sample populations, 
obesity was found to be associated with an increased risk of heart failure [26] and accelerated 
progression of atherosclerosis [27]. Increased adiposity has been established as an independent 
predictor of coronary heart disease, with a risk increase of 8% for each increment of BMI [28].  
Increased adiposity is linked to cancer via three main factors: the insulin – IGF-1 axis, 
sex hormones and adipocyte-derived cytokines, with local metabolic alterations in adipose 
tissue provoking multiple systemic metabolic alterations and contributing to tumour 
development [29, 30]. A large population-based cohort study of more than five million UK 
adults found linear positive associations between BMI increase and cancers of the uterus, 
gallbladder, kidney, cervix, thyroid and leukaemia, along with a positive link between BMI 
and liver, colon, ovarian and post-menopausal breast cancers [31]. A meta-analysis involving 
more than 280,000 cancer cases revealed associations between BMI increase and malignant 
melanoma and rectal cancers in men, endometrial, gallbladder, postmenopausal breast and 
pancreatic cancers in women, and oesophageal adenocarcinoma, leukaemia, multiple 
myeloma, non-Hodgkin lymphoma, colon, thyroid and renal cancer in both sexes [32]. Pre-
diagnosis BMI is an important independent preoperative factor of survival in non-metastatic 
colorectal cancer [33]. Increasing BMI in patients with rectal cancer is associated with a higher 
chance of local recurrence and decreased likelihood of sphincter preservation [34]. The risk of 
death also increases depending on BMI in stomach and prostate cancers in men and cancers of 
the breast, uterus, cervix and ovary in women, with estimated a contribution of overweight and 
obesity to cancer mortality of 14–20% [35]. 
Weight gain in adults is a strong and independent risk factor for premature death [36]. 
In a large pooled analysis of 20 studies, it was estimated that obesity was associated with 
significantly increased rates of mortality, mostly due to heart disease, cancer and diabetes, and 
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the life expectancy of Class III obese individuals was substantially reduced compared with 
those of normal weight, with 6.5 years of life lost for BMI of 40–44.9 kg/m2 up to 13.7 years 
for BMI of 55–59.9 kg/m2 [37]. Although overall life expectancy did not appear to change in 
Class I (mild) obesity, disability-free life expectancy decreased by 2.7 years [38]; for all classes 
of obesity combined, disability-free life expectancy decreased by 4.5 years [39]. Given the high 
prevalence of obesity, it can have a nationwide effect, and obesity reduced the estimated life 
expectancy in the USA at age 50 years by 1.54 years [40]. 
1.1.4 Costs of obesity 
In the United States, the direct medical costs of overweight and obesity are 
approximately 5 to 10% of healthcare spending in the USA [41]. When also accounting for 
comorbidity-related expenditure, annual spending in 2010 was estimated at $315.8 billion or 
27.5% of total healthcare expenditures in the USA [42]. This was a significant increase from 
$78.5 billion in 1998 [43]. The costs of overweight and obesity were projected to reach $861 
billion in 2030 [44].  
The relationship between medical costs and BMI is J-shaped, with an exponential 
increase in costs in Class II and Class III obesity; the higher the BMI, the greater the cost 
reduction is in medical care associated with weight loss [42]. National cost estimates from the 
USA demonstrate significantly higher hospital costs for operative procedures as well as length 
of stay and an increased number of diagnostic and therapeutic procedures in obese patients 
compared with non-obese patients, despite equivalent postoperative complication rates [45]. 
In addition to direct healthcare costs, indirect costs due to lost productivity and early 
premature mortality are even higher than direct costs and contribute 54–59% to the total 
estimated costs [46]. Employees with a BMI over 30 kg/m2 have the greatest short-term 
disability costs and days and lowest productivity [47]. The costs for short-term disability and 
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worker’s compensation claims were more than twice as high for morbidly obese employees 
[48]. 
The evidence from Australia shows that in the obese population aged 45 and over, 
compared with normal weight individuals, average annual health expenditures are estimated to 
be 19% higher for Class I obesity and 51% higher for Class II and Class III obesity, with 
significant differences in all types of care: emergency departments, inpatient hospital costs, 
outpatient costs and prescription drugs [49].  
The total Australian direct costs of overweight and obesity in 2005 were estimated to 
be $21.0 billion, and the direct costs of obesity were estimated to be $8.3 billion. A significant 
burden was taken by the government, with average annual costs of subsidies for overweight 
and obesity of $3917 per person and a total cost of $35.6 billion per year [50]. Productivity 
loss costs were estimated at $637 million in 2005 [51] and $3.6 billion in 2008 [52]. The 
distribution of the burden of the financial costs in 2005 was 29.1% borne by individuals, 16.4% 
by family and friends, 37.0% by the federal government, 5.0% by state governments, 0.1% by 
employers and 12.4% by the rest of society [52].  
1.2 Treatment of obesity 
1.2.1 Diet and lifestyle modification 
Diet and lifestyle modifications are the basis of all treatment guidelines and a part of 
multicomponent comprehensive intervention, with implementation of simultaneous strategies 
developed to change an individual’s behaviour, reduce overall energy intake and increase 
energy expenses by promoting physical activity [3, 53, 54]. In a study of more than 5,000 
overweight and obese adults with type 2 diabetes, intensive lifestyle interventions over the 
course of eight years in certain participants produced clinically meaningful weight loss, defined 
as 5% or more of body mass, and could be used to manage obesity and obesity-related 
conditions. However, this effect, including long-term weight maintenance, was observed only 
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in half of participants [55]. The Diabetes Prevention Program demonstrated that despite weight 
regain in the lifestyle intervention population, the benefit in terms of reduction of type 2 
diabetes incidence (prevention or delay of diabetes) still persisted for at least 10 years [56]. A 
systematic review showed that although absolute weight loss with intensive lifestyle 
intervention continuing for a year is modest and is on average 8 kg, it nevertheless translates 
into health benefits and improvements in blood pressure, lipid levels and glycaemic control 
[54]. Commercially available interventions with durations of up to one year produce an average 
weight loss of 3% [57]. 
Weight loss diets should provide less energy than is expended daily. The widespread 
belief in the existence of an ideal diet is not supported by the available literature, and large 
studies and meta-analyses have not found significant differences in weight loss among low-
calorie diets composed of different nutritional proportions [58, 59]. Therefore, the main 
characteristic of the provided dietary intervention for weight loss should be ease of adherence 
[60]. However, diets can provide other benefits, and meta-analyses have found that 
Mediterranean diets are associated with cardiovascular risk reduction [61, 62]. 
Very low calorie diets (200–800 kcal/day) provide rapid initial weight loss; however, 
the long-term effects of these diets are not different from those of other dietary approaches, 
and therefore their recommendation should be limited to clinically necessary rapid weight loss, 
such as for preoperative preparation [53, 63]. 
Adding physical activity to dietary interventions can result in an additional 1–1.5 kg 
average weight loss over a 1-year period with general health benefits [53, 64], although the 
weight loss effect is not sustainable [55]. Table 1 summarises comprehensive lifestyle 
interventions [65]. 
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Table 1. Elements of comprehensive lifestyle interventions for overweight and obesity 




Multiple methods are effective: 
• Set a caloric goal (1,200–1,500 kcal/day for women, 1,500–1,800 kcal/day 
for men, adjusted for body weight) 
• Specify a caloric deficit (500 or 750 kcal/ day) 
• Restrict/reduce intake of certain food types (e.g., high-carbohydrate, low-
fibre, or high-fat foods) to create energy deficit 
• Consider patient preferences and health status when identifying a diet–a 
variety of approaches can produce weight loss 
Increased physical 
activity 
Aerobic activity > 150 min/week for weight loss 
Resistance training to preserve lean mass  




• Face-to-face sessions (≥ 14 with a trained interventionist over the first 6 
months) 
• Maintain efforts over 1 year 
• Incorporate strategies such as goal-setting and self-monitoring 
Alternatives to face-to-face counselling: 
• Telephone or electronic counselling with a trained interventionist 
• Commercial weight loss programs 
• Tend to produce less weight loss than face-to-face counselling 
Maintenance: 
• Continued contact (once monthly) with a trained interventionist 
 
1.2.2 Pharmacological treatment 
Pharmacological treatment is the next stage in the step-wise approach to obesity 
treatment and is recommended if non-pharmacological treatment fails to achieve 5% weight 
loss of the initial body weight [53, 54, 66]. Pharmacological treatment is recommended by the 
Endocrine Society (USA) for overweight individuals with a BMI over 27 kg/m2 and one or 
more obesity-related risk factors or for individuals with BMI over 30 kg/m2 [65]. Five weight 
loss medications are currently approved in the USA for chronic weight management, three of 
those are approved in the European Union, three are approved in Australia, and one more is 
available for off-label use (Table 2) [60, 67]. 
Pharmacotherapy should be guided by three principles [66]. First, pharmacotherapy 
should not be the only intervention but accompany and reinforce lifestyle and dietary 
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interventions. Second, patients and prescribers should be familiar with the side-effect profiles 
of the medications and understand their effects and expected effectiveness. Third, if clinically 
significant weight loss (defined as 5% of total body weight) has not been achieved within 3–4 
months, a new treatment strategy should be implemented. Weight loss at this point is a predictor 
of weight loss over a long-term period [65].  
When using pharmacological therapy, patients should be closely monitored for the first 
three months (or longer for medications with a gradual dose increase) to assess safety, 
tolerability and efficacy, and medication should be ceased or replaced in case any concerns 
arise [67]. 
Table 2. Medications for weight loss management (adapted from Bray, Ching Lee [60, 67]) 









Phentermine Sympathomimetic Yes No Yes Not stated Inexpensive Side-effect 
profile; no 
long-term data 
Orlistat Pancreatic lipase 
inhibitor 








Lorcaserin 5–HT2c serotonin 
agonist 

































Liraglutide GLP-1 receptor 
agonist 







In addition to well-justified reasons for therapy cessation, it is not uncommon for 
effective pharmacological therapy to be discontinued despite a requirement to continue therapy 
to maintain the effect. Reasons for therapy discontinuation include costs, concerns about side 
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effects and the perception that the medication is no longer required after some weight loss is 
achieved [68]. However, given that the current concept of obesity suggests that it is a chronic 
and relapsing disease, intervention should be continued even after target points are achieved, 
similar to blood pressure or diabetes control [67]. 
1.2.3 Bariatric surgery 
Surgical treatment of obesity is considered the most effective treatment method with 
the best results in terms of weight loss and improvement or resolution of obesity-related 
comorbidities, regardless of the type of the surgical procedure used [69]. However, this 
effectiveness relates to modern procedures, and a range of procedures have been abandoned, 
although individuals who have undergone those procedures can still be encountered. Figure 3 
demonstrates the evolution of bariatric procedures over time [70]. 
More than 50 years ago, a procedure of jejuno-ileal bypass was introduced to create 
malabsorption through the creation of artificial short gut syndrome, mostly in individuals with 
a BMI over 50. In this procedure, the proximal 35 cm of the jejunum was anastomosed to the 
distal ileum 10 cm from the ileocaecal valve [71]. The surgery resulted in diabetes 
improvement but was accompanied with a large number of side effects and complications, such 
as liver failure secondary to anaerobic bacterial translocation, hypoproteinaemia, steatorrhea, 
nephrolithiasis due to calcium binding to fatty acids, and increased oxalate absorption and 
abdominal bloating. Although the majority of the patients achieved their weight loss goals, the 
side-effects profile caused this operation to be replaced with safer procedures [72]. 
Different variants of gastroplasty were used to restrict the stomach volume and decrease 
food intake by creating a small gastric reservoir. Initially, the technique of horizontal 
gastroplasty was used; however, the reservoir and its outlet dilated quickly, and the restrictive 
effect disappeared [73]. In the most common variant of gastroplasty, a stapled channel was 
formed along the lesser curvature banded with a mesh or a band. Initially promising good 
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weight loss results, this procedure had a high long-term complication rate due to obstruction, 
band erosion, and weight regain [74] and was eventually abandoned [71]. 
 
Figure 3. The evolution of bariatric surgery procedures from the 1950s to 1990s (reproduced 
from Arterburn et al., 2014 [70]). 
1.2.3.1 Adjustable gastric banding 
The first gastric band was described in 1978, and the first adjustable gastric band was 
used in 1985 [75, 76]. In the 1990s, adjustable gastric banding became a widely used procedure, 
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performed mostly laparoscopically (LAGB), in which a band restricting food passage to the 
proximal stomach is placed. The restriction can be adjusted by filling a band with saline through 
a subcutaneous port connected to the band via a tubing system (Figure 4). Optimal restriction 
should reduce food intake, cause early satiety with a small food amount and not cause 
obstruction or dysphagia [77, 78]. 
A large meta-analysis of long-term follow-up studies demonstrated that the average 
percentage of excess weight loss 15 years post-surgery was 47.1% [79]. Revisions were 
performed in 50.4% of cases for the following reasons: pouch enlargement – 26.0%, band 
erosion – 3.4%, port/tubing problems – 21.0%, band explantations – 5.6%. It should be noted 
that revision rates decreased with the evolution of the technique. Certain studies provided even 
higher rates of band removals of up to 48.6–52.2%. Those studies also showed suboptimal 
satisfaction levels with the operation results (42–63%); a study examining long-term results in 
super-obese patients demonstrated that only 11% of patients with a BMI of 50 kg/m2 or higher 
achieved and maintained weight loss of 50% over a 10-year period [80-82].  
Worldwide, the LAGB procedure reached its peak in 2008, when it constituted 42.3% 
of all bariatric procedures. Since then, its popularity has declined, and in 2013, only 10% of 
bariatric procedures were performed as LAGB [83]. In the International Federation for Surgery 
for Obesity and Metabolic Diseases (IFSO) Global Registry of the total number of primary 
procedures performed in 2013–2017, only 6% were gastric bands [84]. Australian data show 
that in the financial year 2014/2015, 26.5% of registered procedures were LAGB, and this 
proportion decreased to 9.2% in 2016/2017 [85]. 




Figure 4. Adjustable gastric banding (reproduced from Neff et al. [86]). 
1.2.3.2 Sleeve gastrectomy 
Sleeve gastrectomy (SG) involves the creation of a narrow gastric sleeve using surgical 
staplers close to the lesser curvature and the removal of a significant portion of the stomach 
(Figure 5). Initially, SG was performed as the first stage of a two-stage duodenal switch (DS) 
procedure for patients with severe obesity and significant comorbidities, and SG started to be 
used as a stand-alone procedure in 2001, with the first results published in 2003 [87, 88]. 
The mechanism of action of this procedure cannot be explained purely by restriction 
due to stomach volume reduction. SG is accompanied by a significant decrease in ghrelin levels 
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[89] and an increase in the levels of GLP-1 and peptide-YY [90], thus providing an incretin 
effect similar to that observed after the gastric bypass procedure [91]. 
In the following two years, multiple studies demonstrated good short- and medium-
term results, with average excess weight loss of 51% in the first 6 months and 63% in one year 
[92-97]. The proportion of SGs increased from 5.3% in 2008 to 37% in 2013 [83], thus 
becoming more popular than LAGB. SG constituted 43.6% of primary procedures in the IFSO 
Global Registry in 2013–2017 [84]. In the Australian Registry, its proportion increased from 
49.1% in FY 2014/2015 to 65.3% in FY 2016/2017 [85]. This increase can be explained 
because the operative technique is relatively simple, does not involve the creation of 
anastomoses, and preserves physiological gastrointestinal continuity as well as the possibility 
of conversion to other types of bariatric procedure if required [98, 99]. 
 
Figure 5. Sleeve gastrectomy (reproduced from Neff et al. [86]). 
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1.2.3.3 Gastric bypass 
The procedure of Roux-en-Y gastric bypass (RYGB) combines malabsorptive and restrictive 
components by creating a small reservoir in the proximal stomach, which is anastomosed with 
the distal jejunum (Figure 6). The length of loops and types of anastomoses vary greatly [100-
103]. 
 
Figure 6. Roux-en-Y gastric bypass (reproduced from Neff et al. [86]). 
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One of the mechanisms of action in this operation is the incretin effect caused by early 
food passage to the midgut [104]. It also modifies food behaviour by decreasing the reward 
value of sweet and fatty food [105] as well forcing a decrease in high carbohydrate food 
consumption due to high rates (10%–21%) of dumping syndrome [106]. The procedure has 
good and sustainable weight loss results in the long-term period, with weight loss of over 60% 
according to some studies [107, 108]. 
This procedure has a relatively high long-term complication rate due to complications 
specific to this procedure, such as internal hernias (1–9%) [109-112], anastomotic strictures 
(3%–23%) [113, 114], marginal ulcers (1%–16%) [115, 116], gastro-gastric fistulas (1.5–6%) 
[117, 118], and anaemia due to iron or folic acid deficiency (20–49%) [119, 120]. 
This is one of the oldest procedures and has been performed since the 1970s. It remains 
the most commonly performed bariatric procedure in the world, but its proportion among other 
procedures decreased from 65% in 2003 to 45% in 2013 as SG increased in popularity [83]. In 
the IFSO Global Registry, 46.3% of primary procedures are different modifications of gastric 
bypass [84]. In the Australian Registry, the proportion of RYGB has remained stable at 
approximately 10% over the years [85]. 
1.2.3.4 Biliopancreatic diversion and duodenal switch 
Biliopancreatic diversion (BPD) and duodenal switch (DS) procedures are performed 
as resection of a portion of the stomach (distal gastrectomy in BPD and sleeve gastrectomy in 
DS), with division of the gastrointestinal tract into alimentary and biliopancreatic channels and 
a short common loop where digestion and absorption occur (Figure 7). 
These procedures are very effective in patients with a BMI of over 50 kg/m2, with 
excess weight loss over 70% [87, 121-123]. For patients with initial a BMI of 40 to 50 kg/m2, 
excess weight loss was 82% one year after surgery and 96% 18 months post-surgery [124, 125]. 
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In the series of patients with a BMI of less than 40 kg/m2, excess weight loss was over 100% 
[125, 126]. 
 
Figure 7. Biliopancreatic diversion (duodenal switch) (reproduced from Neff et al. [86]). 
The complication rate, however, is very high and was at least 10% in the reports with 
the lowest rates [123] and 15–20% on average in other series [121, 127]. Among short-term 
complications, the most common were intra-abdominal bleeding (2.4–3.4%) [122, 128], intra-
abdominal abscesses (up to 5.0%) [122], and duodeno-ileal anastomotic leaks in DS (1.0–
1.9%), which are the main cause of mortality in these operations [121, 123, 127]. 
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Long-term complications include nutritional deficiencies and severe malabsorption, 
with a rate of revisional operations for these reasons of up to 0.1% annually [121]. 
These procedures are not common and constitute only 1.5% of bariatric procedures 
worldwide [83]. Due to the technical complexity of those procedures, 8% are performed 
laparoscopically [107]. BPD and DS are not reported to be performed in Australia. 
1.2.3.5 Indications and eligibility for bariatric surgery 
The International Federation for the Surgery of Obesity - European Chapter (IFSO-EC) 
and European Association for the Study of Obesity (EASO) produced guidelines [129] 
recommending bariatric surgery for individuals aged from 18 to 60 years with a BMI over 40 
kg/m2 or for persons with a BMI of 35–40 kg/m2 with comorbidities for which surgically 
induced weight loss is expected to improve the disorder (such as metabolic disorders, 
cardiorespiratory disease, severe joint disease, and obesity-related severe psychological 
problems). The BMI criterion used may be either current BMI or previous maximum attained 
BMI, implying that weight loss because of intensive treatment is not a contraindication to 
planned bariatric surgery and that weight regain after a substantial weight loss can be an 
indication for surgery. There are also special categories of patients for whom bariatric surgery 
should be considered by taking the individual situation into account, namely, patients with BMI 
of 30–35 kg/m2 with type 2 diabetes, patients aged over 60, and adolescents with BMI over 40 
kg/m2 with at least one comorbidity who demonstrate maturity and adherence to a weight loss 
program.  
The European guidelines also specifically mention contraindications to bariatric 
surgery: absence of a period of medical management, inability to participate in follow-up, non-
stabilised mental disorders, alcohol or drug abuse, diseases threatening life in the short-term, 
and inability to care for themselves with a lack of support. 
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Based on the categories of patients who benefit the most from bariatric surgery, the 
Australian National Health and Research Council guidelines recommend bariatric surgery for 
adults with a BMI over 40 kg/m2; for adults with a BMI over 35 kg/m2 and comorbidities that 
may improve with weight loss, bariatric surgery may be considered, taking into account the 
individual situation. Bariatric surgery may be a consideration for people with a BMI > 30 kg/m2 
who have poorly controlled type 2 diabetes and are at increased cardiovascular risk, taking into 
account the individual situation [2]. 
 We estimated that the number of Australians eligible for bariatric surgery according to 
these guidelines was more than 800,000 in 2011–2013, with nearly 400,000 having Class III 
obesity. Of that population, 46% did not have private health insurance, making this a problem 
of great significance for public healthcare [130]. Despite the potential demand for public 
bariatric surgery, not all Australian states and territories have guidelines and policies for 
bariatric surgery, and five states and territories with those guidelines have significant variations 
and lack full consistency with the national guidelines. The guidance for prioritising patients is 
quite limited [131]. 
1.2.3.6 Revisional bariatric surgery 
While bariatric surgery is the most effective modality of treatment for severe obesity 
and its comorbidities, the success rate is not 100%, and subsequent revisional surgeries are 
occasionally required for undesirable results of the initial operation. The current paradigm of 
revisional bariatric surgery views obesity as a chronic disease that, like other chronic diseases, 
will have long-term failures with any treatment modality and require treatment escalation in 
some patients [132, 133]. 
Revisional bariatric surgery has a well-established, short-term complication rate that is 
higher than those for similar primary procedures but is considered acceptable by surgeons [134, 
135].  
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The two most common reasons for revisional surgery are weight loss failure (either as 
insufficient weight loss or weight recidivism after initially successful results) and 
complications of the initial surgery [133]. Revisional surgery for complications aims to correct 
the specific complication and is usually tailored to it. Revisional surgery for obesity 
management failure provides more options for the surgeon: it can be directed to the specific 
cause of unsuccessful weight loss (such as LAGB replacement for its malfunction or narrowing 
a wide gastro-jejunal anastomosis in RYGB), or one procedure can be converted into another, 
such as the anatomy of sleeve gastrectomy can be transformed into RYGB. Multiple types of 
revisions have been described depending on the primary procedure, including procedures that 
were abandoned during the evolution of bariatric surgery; however, patients with anatomy 
altered by those procedures may still be encountered in bariatric practice [132]. 
1.2.3.7 Bariatric surgery in Australia 
The majority of available data on bariatric surgery performed in Australia comes from 
Australian Institute of Health and Welfare (AIHW) reports and from the Bariatric Surgery 
Registry (BSR) [85, 136]. 
Overall, the number of bariatric procedures has increased over time, with 9,300 weight 
loss surgeries performed in 2005–2006 and 22,700 in 2014–2015. Bariatric surgery in Australia 
is performed in both public and private systems, with the majority (89%) of procedures being 
performed in private systems. More than one-third of the public procedures are reported to be 
performed in Victorian hospitals. Tasmania had the highest number of public bariatric 
procedures per capita nationally in 2014–2015, with 2.7 procedures per 10,000 population 
(Figure 8). 




Figure 8. Separation rates (per 10,000 population) for weight loss surgery by public and 
private hospitals, states and territories in Australia, 2014–15 (reproduced from Australian 
Institute of Health and Welfare report, 2017 [136]; no data on Tasmanian private hospitals 
were available in the report). 
Although Classes 2 and 3 of obesity are somewhat more prevalent in Australian females, 
there is a marked disproportion in the sex of bariatric surgery patients, and 79.1% of bariatric 
surgery recipients are females [136]. 
There have been changes in the proportions of different types of bariatric procedures 
performed in Australia. In 2011, Australia was the only reported country in which the majority 
of bariatric procedures were adjustable gastric banding (7,200 out of 12,000, or 60%) [137]. 
By 2013, the situation had changed, and the proportion of adjustable gastric banding dropped 
to 30%, with sleeve gastrectomy representing more than 60% of bariatric procedures [83]. The 
BSR, despite not capturing all procedures, demonstrates similar trends in terms of the decline 
in adjustable gastric banding and increase in sleeve gastrectomy (Figure 9). 




Figure 9. Changes in procedure type captured by the BSR (SAGB – single anastomosis 
gastric bypass; RYGB – Roux-en-Y gastric bypass; LAGB – laparoscopic adjustable gastric 
banding; LSG – laparoscopic sleeve gastrectomy) (reproduced from the Fifth Annual Report 
of the Bariatric Surgery Registry, 2017 [85]). 
Revisional bariatric surgery trends have changed over time, especially in the public 
sector. According to the AIHW report, the proportion of revisional procedure separations in 
the public sector increased from 19.5% in 2005–2006 to 36.7%, whereas revisions in the private 
sector decreased [136]. 
The increasing number of procedures performed, especially with the increase in more 
complex revisional procedures and the shift to the public sector, requires further investigation 
of hospital service use by bariatric patients, both primary and revisional. In particular, studies 
are needed in areas not mentioned or surveyed in the reports, such as determining and 
describing patient pathways to understand the relationships between primary surgical 
procedures and subsequent revisions [136].  
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1.3 Summary and research aims 
Obesity is a significant problem, with the majority of adult Australians being 
overweight or obese. The association of obesity with multiple comorbidities, particularly type 
2 diabetes, is well established. The burden of obesity and obesity-related comorbidities has a 
significant economic impact and reduces quality of life and life expectancy. 
Among multiple treatment modalities for obesity, bariatric surgery is currently the most 
effective and has long-term effects. Bariatric surgery is included in different national and 
international guidelines, and in many countries, including Australia, it is performed in the 
public sector. Revisional bariatric surgery is not uncommon and has shifted towards the public 
sector compared with privately performed surgeries. According to an Australian Institute of 
Health and Welfare report, in 2014–2015, 37% of bariatric procedures performed in public 
hospitals were revisional in comparison with the 18% of bariatric operations in private hospitals 
[138]. 
In the setting of substantially greater demand for bariatric surgery than supply, such as 
in Tasmania, the impact of bariatric surgery on health service use should be investigated to 
allow better planning of health services provision. 
The aims of this PhD thesis were as follows: 
1. Evaluate public hospital service use by all bariatric patients wait-listed for primary public 
bariatric surgery in Tasmania by investigating and describing public hospital admissions 
(Chapter 2) and emergency department (ED) presentations (Chapter 3) before wait-list 
placement, while waiting, and after removal from the wait-list. 
2. Describe patient pathways and evaluate the need for subsequent revisions and reoperations 
for short- and long-term complications after a secondary (first revision) bariatric surgery 
through a systematic review of the literature (Chapter 4). 
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3. Assess the demand for revisional bariatric surgery in the Tasmanian public sector and 
evaluate the accessibility of publicly funded bariatric surgery and the use of public hospital 
services for patients wait-listed for revisional vs primary bariatric surgery (Chapter 5). 
  




1. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. 
World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253. 
2. National Health and Medical Research Council. Clinical practice guidelines for the 
management of overweight and obesity in adults, adolescents and children in Australia. 
Melbourne: National Health and Medical Research Council; 2013. 
3. Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al. 2013 
AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of 
the American College of Cardiology/American Heart Association Task Force on Practice 
Guidelines and The Obesity Society. Circulation. 2014;129(25 Suppl 2):S102-38. 
4. James WP. WHO recognition of the global obesity epidemic. Int J Obes (Lond). 
2008;32 Suppl 7:S120-6. 
5. Flegal KM, Shepherd JA, Looker AC, Graubard BI, Borrud LG, Ogden CL, et al. 
Comparisons of percentage body fat, body mass index, waist circumference, and waist-stature 
ratio in adults. Am J Clin Nutr. 2009;89(2):500-8. 
6. Phillips CM. Metabolically healthy obesity: definitions, determinants and clinical 
implications. Rev Endocr Metab Disord. 2013;14(3):219-27. 
7. Gomez-Ambrosi J, Silva C, Galofre JC, Escalada J, Santos S, Millan D, et al. Body 
mass index classification misses subjects with increased cardiometabolic risk factors related to 
elevated adiposity. Int J Obes (Lond). 2012;36(2):286-94. 
8. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its 
implications for policy and intervention strategies. Lancet. 2004;363(9403):157-63. 
9. Frayon S, Cherrier S, Cavaloc Y, Wattelez G, Lerrant Y, Galy O. Relationship of body 
fat and body mass index in young Pacific Islanders: a cross-sectional study in European, 
Melanesian and Polynesian groups. Pediatr Obes. 2018;13(6):357-64. 
Chapter 1: Introduction 
27 
 
10. Swinburn BA, Ley SJ, Carmichael HE, Plank LD. Body size and composition in 
Polynesians. Int J Obes Relat Metab Disord. 1999;23(11):1178-83. 
11. Padwal RS, Pajewski NM, Allison DB, Sharma AM. Using the Edmonton obesity 
staging system to predict mortality in a population-representative cohort of people with 
overweight and obesity. CMAJ. 2011;183(14):E1059-66. 
12. Popkin BM, Adair LS, Ng SW. Global nutrition transition and the pandemic of obesity 
in developing countries. Nutr Rev. 2012;70(1):3-21. 
13. Swinburn BA, Sacks G, Hall KD, McPherson K, Finegood DT, Moodie ML, et al. The 
global obesity pandemic: shaped by global drivers and local environments. Lancet. 
2011;378(9793):804-14. 
14. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, 
regional, and national prevalence of overweight and obesity in children and adults during 1980-
2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 
2014;384(9945):766-81. 
15. Australian Bureau of Statistics. National Health Survey: First Results, Asutralia 2014-
15. ABS Catalogue No. 4364.0.55.001. 2015 [Internet]. [Available from: 
http://www.ausstats.abs.gov.au/ausstats/subscriber.nsf/0/CDA852A349B4CEE6CA257F1500
09FC53/$File/national%20health%20survey%20first%20results,%202014-15.pdf. 
16. Australian Institute of Health and Welfare. A picture of overweight and obesity in 
Australia 2017. Cat. no.PHE 216. Canberra: AIHW; 2017. 
17. Australian Bureau of Statistics. National Health Survey: First Results, Asutralia 2014-




Chapter 1: Introduction 
28 
 
18. Apovian CM. Obesity: definition, comorbidities, causes, and burden. Am J Manag 
Care. 2016;22(7 Suppl):s176-85. 
19. Eckel RH, Kahn SE, Ferrannini E, Goldfine AB, Nathan DM, Schwartz MW, et al. 
Obesity and type 2 diabetes: what can be unified and what needs to be individualized? J Clin 
Endocrinol Metab. 2011;96(6):1654-63. 
20. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, et al. Prevalence 
of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289(1):76-9. 
21. Bjorntorp P. Metabolic implications of body fat distribution. Diabetes Care. 
1991;14(12):1132-43. 
22. Deng Y, Scherer PE. Adipokines as novel biomarkers and regulators of the metabolic 
syndrome. Ann N Y Acad Sci. 2010;1212:E1-E19. 
23. Larson-Meyer DE, Newcomer BR, Ravussin E, Volaufova J, Bennett B, Chalew S, et 
al. Intrahepatic and intramyocellular lipids are determinants of insulin resistance in prepubertal 
children. Diabetologia. 2011;54(4):869-75. 
24. Bournat JC, Brown CW. Mitochondrial dysfunction in obesity. Curr Opin Endocrinol 
Diabetes Obes. 2010;17(5):446-52. 
25. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with 
cardiovascular disease. Nature. 2006;444(7121):875-80. 
26. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, et al. Obesity 
and the risk of heart failure. N Engl J Med. 2002;347(5):305-13. 
27. Lakka TA, Lakka HM, Salonen R, Kaplan GA, Salonen JT. Abdominal obesity is 
associated with accelerated progression of carotid atherosclerosis in men. Atherosclerosis. 
2001;154(2):497-504. 
Chapter 1: Introduction 
29 
 
28. Li TY, Rana JS, Manson JE, Willett WC, Stampfer MJ, Colditz GA, et al. Obesity as 
compared with physical activity in predicting risk of coronary heart disease in women. 
Circulation. 2006;113(4):499-506. 
29. Park J, Euhus DM, Scherer PE. Paracrine and endocrine effects of adipose tissue on 
cancer development and progression. Endocr Rev. 2011;32(4):550-70. 
30. Park J, Morley TS, Kim M, Clegg DJ, Scherer PE. Obesity and cancer--mechanisms 
underlying tumour progression and recurrence. Nat Rev Endocrinol. 2014;10(8):455-65. 
31. Bhaskaran K, Douglas I, Forbes H, dos-Santos-Silva I, Leon DA, Smeeth L. Body-mass 
index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK 
adults. Lancet. 2014;384(9945):755-65. 
32. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and 
incidence of cancer: a systematic review and meta-analysis of prospective observational 
studies. Lancet. 2008;371(9612):569-78. 
33. Campbell PT, Newton CC, Dehal AN, Jacobs EJ, Patel AV, Gapstur SM. Impact of 
body mass index on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II 
Nutrition Cohort. J Clin Oncol. 2012;30(1):42-52. 
34. Meyerhardt JA, Tepper JE, Niedzwiecki D, Hollis DR, McCollum AD, Brady D, et al. 
Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II 
and III rectal cancer: findings from Intergroup Trial 0114. J Clin Oncol. 2004;22(4):648-57. 
35. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and 
mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 
2003;348(17):1625-38. 
36. Hu FB, Willett WC, Li T, Stampfer MJ, Colditz GA, Manson JE. Adiposity as 
compared with physical activity in predicting mortality among women. N Engl J Med. 
2004;351(26):2694-703. 
Chapter 1: Introduction 
30 
 
37. Kitahara CM, Flint AJ, Berrington de Gonzalez A, Bernstein L, Brotzman M, MacInnis 
RJ, et al. Association between class III obesity (BMI of 40-59 kg/m2) and mortality: a pooled 
analysis of 20 prospective studies. PLoS Med. 2014;11(7):e1001673. 
38. Reuser M, Bonneux LG, Willekens FJ. Smoking kills, obesity disables: a multistate 
approach of the US Health and Retirement Survey. Obesity (Silver Spring). 2009;17(4):783-9. 
39. van Baal PH, Hoogenveen RT, de Wit GA, Boshuizen HC. Estimating health-adjusted 
life expectancy conditional on risk factors: results for smoking and obesity. Popul Health Metr. 
2006;4:14. 
40. Preston SH, Stokes A. Contribution of obesity to international differences in life 
expectancy. Am J Public Health. 2011;101(11):2137-43. 
41. Tsai AG, Williamson DF, Glick HA. Direct medical cost of overweight and obesity in 
the USA: a quantitative systematic review. Obes Rev. 2011;12(1):50-61. 
42. Cawley J, Meyerhoefer C, Biener A, Hammer M, Wintfeld N. Savings in Medical 
Expenditures Associated with Reductions in Body Mass Index Among US Adults with 
Obesity, by Diabetes Status. Pharmacoeconomics. 2015;33(7):707-22. 
43. Finkelstein EA, Trogdon JG, Cohen JW, Dietz W. Annual medical spending 
attributable to obesity: payer-and service-specific estimates. Health Aff (Millwood). 
2009;28(5):w822-31. 
44. Wang Y, Beydoun MA, Liang L, Caballero B, Kumanyika SK. Will all Americans 
become overweight or obese? estimating the progression and cost of the US obesity epidemic. 
Obesity (Silver Spring). 2008;16(10):2323-30. 
45. Mason RJ, Moroney JR, Berne TV. The cost of obesity for nonbariatric inpatient 
operative procedures in the United States: national cost estimates obese versus nonobese 
patients. Ann Surg. 2013;258(4):541-51; discussion 51-3. 
Chapter 1: Introduction 
31 
 
46. Dee A, Kearns K, O'Neill C, Sharp L, Staines A, O'Dwyer V, et al. The direct and 
indirect costs of both overweight and obesity: a systematic review. BMC Res Notes. 
2014;7:242. 
47. Kleinman N, Abouzaid S, Andersen L, Wang Z, Powers A. Cohort analysis assessing 
medical and nonmedical cost associated with obesity in the workplace. J Occup Environ Med. 
2014;56(2):161-70. 
48. Van Nuys K, Globe D, Ng-Mak D, Cheung H, Sullivan J, Goldman D. The association 
between employee obesity and employer costs: evidence from a panel of U.S. employers. Am 
J Health Promot. 2014;28(5):277-85. 
49. Buchmueller TC, Johar M. Obesity and health expenditures: evidence from Australia. 
Econ Hum Biol. 2015;17:42-58. 
50. Colagiuri S, Lee CM, Colagiuri R, Magliano D, Shaw JE, Zimmet PZ, et al. The cost 
of overweight and obesity in Australia. Med J Aust. 2010;192(5):260-4. 
51. Yates J, Murphy C. A cost benefit analysis of weight management strategies. Asia Pac 
J Clin Nutr. 2006;15 Suppl:74-9. 
52. Access Economics. The growing cost of obesity in 2008: three years on Canberra: 
Diabetes Australia; 2008.  
Available from: https://static.diabetesaustralia.com.au/s/fileassets/diabetes-
australia/7b855650-e129-4499-a371-c7932f8cc38d.pdf. 
53.  Obesity: Identification, Assessment and Management of Overweight and Obesity in 
Children, Young People and Adults: Partial Update of CG43. National Institute for Health and 
Clinical Excellence: Guidance. London2014. 
54. Ryan D, Heaner M. Guidelines (2013) for managing overweight and obesity in adults. 
Preface to the full report. Obesity (Silver Spring). 2014;22 Suppl 2:S1-3. 
Chapter 1: Introduction 
32 
 
55. Look AHEAD Research Group. Eight-year weight losses with an intensive lifestyle 
intervention: the look AHEAD study. Obesity (Silver Spring). 2014;22(1):5-13. 
56. Diabetes Prevention Program Research Group, Knowler WC, Fowler SE, Hamman RF, 
Christophi CA, Hoffman HJ, et al. 10-year follow-up of diabetes incidence and weight loss in 
the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374(9702):1677-86. 
57. Unick JL, Neiberg RH, Hogan PE, Cheskin LJ, Dutton GR, Jeffery R, et al. Weight 
change in the first 2 months of a lifestyle intervention predicts weight changes 8 years later. 
Obesity (Silver Spring). 2015;23(7):1353-6. 
58. Hu T, Mills KT, Yao L, Demanelis K, Eloustaz M, Yancy WS, Jr., et al. Effects of low-
carbohydrate diets versus low-fat diets on metabolic risk factors: a meta-analysis of 
randomized controlled clinical trials. Am J Epidemiol. 2012;176 Suppl 7:S44-54. 
59. Sacks FM, Bray GA, Carey VJ, Smith SR, Ryan DH, Anton SD, et al. Comparison of 
weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med. 
2009;360(9):859-73. 
60. Bray GA, Fruhbeck G, Ryan DH, Wilding JP. Management of obesity. Lancet. 
2016;387(10031):1947-56. 
61. Estruch R, Ros E, Salas-Salvado J, Covas MI, Corella D, Aros F, et al. Primary 
prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 
2013;368(14):1279-90. 
62. Huo R, Du T, Xu Y, Xu W, Chen X, Sun K, et al. Effects of Mediterranean-style diet 
on glycemic control, weight loss and cardiovascular risk factors among type 2 diabetes 
individuals: a meta-analysis. Eur J Clin Nutr. 2015;69(11):1200-8. 
63. Tsai AG, Wadden TA. The evolution of very-low-calorie diets: an update and meta-
analysis. Obesity (Silver Spring). 2006;14(8):1283-93. 
Chapter 1: Introduction 
33 
 
64. Wu T, Gao X, Chen M, van Dam RM. Long-term effectiveness of diet-plus-exercise 
interventions vs. diet-only interventions for weight loss: a meta-analysis. Obes Rev. 
2009;10(3):313-23. 
65. Apovian CM, Garvey WT, Ryan DH. Challenging obesity: Patient, provider, and expert 
perspectives on the roles of available and emerging nonsurgical therapies. Obesity (Silver 
Spring). 2015;23 Suppl 2:S1-S26. 
66. Apovian CM, Aronne LJ, Bessesen DH, McDonnell ME, Murad MH, Pagotto U, et al. 
Pharmacological management of obesity: an endocrine Society clinical practice guideline. J 
Clin Endocrinol Metab. 2015;100(2):342-62. 
67. Ching Lee P, Dixon J. Pharmacotherapy for obesity. Australian Family Physician. 
2017;46(7):472-7. 
68. Jain P, Rostbjerg AS, Haase CL, Rhee NA. Weight loss experiences and willingness to 
intervention with pharmacotherapy among obese and very obese Danish people. Phys 
Sportsmed. 2016;44(3):201-7. 
69. Colquitt JL, Pickett K, Loveman E, Frampton GK. Surgery for weight loss in adults. 
Cochrane Database Syst Rev. 2014(8):CD003641. 
70. Arterburn DE, Courcoulas AP. Bariatric surgery for obesity and metabolic conditions 
in adults. BMJ. 2014;349:g3961. 
71. Deitel M. A brief history of the surgery for obesity to the present, with an overview of 
nutritional implications. J Am Coll Nutr. 2013;32(2):136-42. 
72. Deitel M, Shahi B, Anand PK, Deitel FH, Cardinell DL. Long-term Outcome in a Series 
of Jejunoileal Bypass Patients. Obes Surg. 1993;3(3):247-52. 
73. Gomez CA. Gastroplasty in the surgical treatment of morbid obesity. Am J Clin Nutr. 
1980;33(2 Suppl):406-15. 
Chapter 1: Introduction 
34 
 
74. Mason EE, Doherty C, Cullen JJ, Scott D, Rodriguez EM, Maher JW. Vertical 
gastroplasty: evolution of vertical banded gastroplasty. World J Surg. 1998;22(9):919-24. 
75. Kuzmak LI. A Review of Seven Years' Experience with Silicone Gastric Banding. Obes 
Surg. 1991;1(4):403-8. 
76. Wilkinson LH, Peloso OA. Gastric (reservoir) reduction for morbid obesity. Arch Surg. 
1981;116(5):602-5. 
77. Burton PR, Yap K, Brown WA, Laurie C, O'Donnell M, Hebbard G, et al. Changes in 
satiety, supra- and infraband transit, and gastric emptying following laparoscopic adjustable 
gastric banding: a prospective follow-up study. Obes Surg. 2011;21(2):217-23. 
78. Burton PR, Yap K, Brown WA, Laurie C, O'Donnell M, Hebbard G, et al. Effects of 
adjustable gastric bands on gastric emptying, supra- and infraband transit and satiety: a 
randomized double-blind crossover trial using a new technique of band visualization. Obes 
Surg. 2010;20(12):1690-7. 
79. O'Brien PE, MacDonald L, Anderson M, Brennan L, Brown WA. Long-term outcomes 
after bariatric surgery: fifteen-year follow-up of adjustable gastric banding and a systematic 
review of the bariatric surgical literature. Ann Surg. 2013;257(1):87-94. 
80. Himpens J, Cadiere GB, Bazi M, Vouche M, Cadiere B, Dapri G. Long-term outcomes 
of laparoscopic adjustable gastric banding. Arch Surg. 2011;146(7):802-7. 
81. Arapis K, Chosidow D, Lehmann M, Bado A, Polanco M, Kamoun-Zana S, et al. Long-
term results of adjustable gastric banding in a cohort of 186 super-obese patients with a BMI>/= 
50 kg/m2. J Visc Surg. 2012;149(2):e143-52. 
82. Yildiz BD, Bostanoglu A, Sonisik M, Bostanoglu S, Hamamci EO, Avsar MF. Long 
term efficacy of laparoscopic adjustable gastric banding--retrospective analysis. Adv Clin Exp 
Med. 2012;21(5):615-9. 
Chapter 1: Introduction 
35 
 
83. Angrisani L, Santonicola A, Iovino P, Formisano G, Buchwald H, Scopinaro N. 
Bariatric Surgery Worldwide 2013. Obes Surg. 2015;25(10):1822-32. 
84. Higa K, Himpens J, Welbourn R, Dixon J, Kinsman R, Walton P. Third IFSO Global 
Registry Report. Henley-on-Thames, RG9 1AY, UK: Dendrite Clinical Systems Ltd; 2017. p. 
72. 
85. School of Public Health and Preventive Medicine Monash University, Obesity Society 
of Australia and New Zealand. Fifth annual report of the Bariatric Surgery Registry. 2017. 
86. Neff KJ, le Roux CW. Bariatric surgery: a best practice article. J Clin Pathol. 
2013;66(2):90-8. 
87. Hess DS, Hess DW, Oakley RS. The biliopancreatic diversion with the duodenal 
switch: results beyond 10 years. Obes Surg. 2005;15(3):408-16. 
88. Regan JP, Inabnet WB, Gagner M, Pomp A. Early experience with two-stage 
laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes 
Surg. 2003;13(6):861-4. 
89. Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK. Weight loss, appetite 
suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-
en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg. 
2008;247(3):401-7. 
90. Peterli R, Wolnerhanssen B, Peters T, Devaux N, Kern B, Christoffel-Courtin C, et al. 
Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-
en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial. Ann 
Surg. 2009;250(2):234-41. 
91. Jimenez A, Casamitjana R, Flores L, Viaplana J, Corcelles R, Lacy A, et al. Long-term 
effects of sleeve gastrectomy and Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus 
in morbidly obese subjects. Ann Surg. 2012;256(6):1023-9. 
Chapter 1: Introduction 
36 
 
92. Baltasar A, Serra C, Perez N, Bou R, Bengochea M, Ferri L. Laparoscopic sleeve 
gastrectomy: a multi-purpose bariatric operation. Obes Surg. 2005;15(8):1124-8. 
93. Langer FB, Bohdjalian A, Felberbauer FX, Fleischmann E, Reza Hoda MA, Ludvik B, 
et al. Does gastric dilatation limit the success of sleeve gastrectomy as a sole operation for 
morbid obesity? Obes Surg. 2006;16(2):166-71. 
94. Langer FB, Reza Hoda MA, Bohdjalian A, Felberbauer FX, Zacherl J, Wenzl E, et al. 
Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg. 
2005;15(7):1024-9. 
95. Milone L, Strong V, Gagner M. Laparoscopic sleeve gastrectomy is superior to 
endoscopic intragastric balloon as a first stage procedure for super-obese patients (BMI > or 
=50). Obes Surg. 2005;15(5):612-7. 
96. Mognol P, Chosidow D, Marmuse JP. Laparoscopic sleeve gastrectomy as an initial 
bariatric operation for high-risk patients: initial results in 10 patients. Obes Surg. 
2005;15(7):1030-3. 
97. Moon Han S, Kim WW, Oh JH. Results of laparoscopic sleeve gastrectomy (LSG) at 1 
year in morbidly obese Korean patients. Obes Surg. 2005;15(10):1469-75. 
98. Dapri G, Cadiere GB, Himpens J. Laparoscopic repeat sleeve gastrectomy versus 
duodenal switch after isolated sleeve gastrectomy for obesity. Surg Obes Relat Dis. 
2011;7(1):38-43. 
99. Iannelli A, Schneck AS, Noel P, Ben Amor I, Krawczykowski D, Gugenheim J. Re-
sleeve gastrectomy for failed laparoscopic sleeve gastrectomy: a feasibility study. Obes Surg. 
2011;21(7):832-5. 
100. Bendewald FP, Choi JN, Blythe LS, Selzer DJ, Ditslear JH, Mattar SG. Comparison of 
hand-sewn, linear-stapled, and circular-stapled gastrojejunostomy in laparoscopic Roux-en-Y 
gastric bypass. Obes Surg. 2011;21(11):1671-5. 
Chapter 1: Introduction 
37 
 
101. Edwards MA, Jones DB, Ellsmere J, Grinbaum R, Schneider BE. Anastomotic leak 
following antecolic versus retrocolic laparoscopic Roux-en-Y gastric bypass for morbid 
obesity. Obes Surg. 2007;17(3):292-7. 
102. Giordano S, Salminen P, Biancari F, Victorzon M. Linear stapler technique may be 
safer than circular in gastrojejunal anastomosis for laparoscopic Roux-en-Y gastric bypass: a 
meta-analysis of comparative studies. Obes Surg. 2011;21(12):1958-64. 
103. Muller MK, Guber J, Wildi S, Guber I, Clavien PA, Weber M. Three-year follow-up 
study of retrocolic versus antecolic laparoscopic Roux-en-Y gastric bypass. Obes Surg. 
2007;17(7):889-93. 
104. Borg CM, le Roux CW, Ghatei MA, Bloom SR, Patel AG, Aylwin SJ. Progressive rise 
in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains 
altered satiety. Br J Surg. 2006;93(2):210-5. 
105. Miras AD, Jackson RN, Jackson SN, Goldstone AP, Olbers T, Hackenberg T, et al. 
Gastric bypass surgery for obesity decreases the reward value of a sweet-fat stimulus as 
assessed in a progressive ratio task. Am J Clin Nutr. 2012;96(3):467-73. 
106. Heraief R, Giusti V. [Prevalence of early and late dumping after gastric bypass]. Rev 
Med Suisse. 2014;10(423):696-8, 700. 
107. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, et al. Weight and 
type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 
2009;122(3):248-56 e5. 
108. Skroubis G, Kouri N, Mead N, Kalfarentzos F. Long-term results of a prospective 
comparison of Roux-en-Y gastric bypass versus a variant of biliopancreatic diversion in a non-
superobese population (BMI 35-50 kg/m(2)). Obes Surg. 2014;24(2):197-204. 
109. Carmody B, DeMaria EJ, Jamal M, Johnson J, Carbonell A, Kellum J, et al. Internal 
hernia after laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2005;1(6):543-8. 
Chapter 1: Introduction 
38 
 
110. Higa KD, Ho T, Boone KB. Internal hernias after laparoscopic Roux-en-Y gastric 
bypass: incidence, treatment and prevention. Obes Surg. 2003;13(3):350-4. 
111. Schneider C, Cobb W, Scott J, Carbonell A, Myers K, Bour E. Rapid excess weight 
loss following laparoscopic gastric bypass leads to increased risk of internal hernia. Surg 
Endosc. 2011;25(5):1594-8. 
112. Steele KE, Prokopowicz GP, Magnuson T, Lidor A, Schweitzer M. Laparoscopic 
antecolic Roux-en-Y gastric bypass with closure of internal defects leads to fewer internal 
hernias than the retrocolic approach. Surg Endosc. 2008;22(9):2056-61. 
113. Alasfar F, Sabnis AA, Liu RC, Chand B. Stricture rate after laparoscopic Roux-en-Y 
Gastric bypass with a 21-mm circular stapler: the Cleveland Clinic experience. Med Princ 
Pract. 2009;18(5):364-7. 
114. Mathew A, Veliuona MA, DePalma FJ, Cooney RN. Gastrojejunal stricture after 
gastric bypass and efficacy of endoscopic intervention. Dig Dis Sci. 2009;54(9):1971-8. 
115. Csendes A, Burgos AM, Altuve J, Bonacic S. Incidence of marginal ulcer 1 month and 
1 to 2 years after gastric bypass: a prospective consecutive endoscopic evaluation of 442 
patients with morbid obesity. Obes Surg. 2009;19(2):135-8. 
116. Sapala JA, Wood MH, Sapala MA, Flake TM, Jr. Marginal ulcer after gastric bypass: 
a prospective 3-year study of 173 patients. Obes Surg. 1998;8(5):505-16. 
117. Cucchi SG, Pories WJ, MacDonald KG, Morgan EJ. Gastrogastric fistulas. A 
complication of divided gastric bypass surgery. Ann Surg. 1995;221(4):387-91. 
118. Tucker ON, Szomstein S, Rosenthal RJ. Surgical management of gastro-gastric fistula 
after divided laparoscopic Roux-en-Y gastric bypass for morbid obesity. J Gastrointest Surg. 
2007;11(12):1673-9. 
Chapter 1: Introduction 
39 
 
119. Allied Health Sciences Section Ad Hoc Nutrition Committee, Aills L, Blankenship J, 
Buffington C, Furtado M, Parrott J. ASMBS Allied Health Nutritional Guidelines for the 
Surgical Weight Loss Patient. Surg Obes Relat Dis. 2008;4(5 Suppl):S73-108. 
120. Lopez PP, Patel NA, Koche LS. Outpatient complications encountered following Roux-
en-Y gastric bypass. Med Clin North Am. 2007;91(3):471-83, xii. 
121. Marceau P, Hould FS, Simard S, Lebel S, Bourque RA, Potvin M, et al. Biliopancreatic 
diversion with duodenal switch. World J Surg. 1998;22(9):947-54. 
122. Sovik TT, Taha O, Aasheim ET, Engstrom M, Kristinsson J, Bjorkman S, et al. 
Randomized clinical trial of laparoscopic gastric bypass versus laparoscopic duodenal switch 
for superobesity. Br J Surg. 2010;97(2):160-6. 
123. Weiner RA, Blanco-Engert R, Weiner S, Pomhoff I, Schramm M. Laparoscopic 
biliopancreatic diversion with duodenal switch: three different duodeno-ileal anastomotic 
techniques and initial experience. Obes Surg. 2004;14(3):334-40. 
124. Praveen Raj P, Kumaravel R, Chandramaliteeswaran C, Rajpandian S, Palanivelu C. Is 
laparoscopic duodenojejunal bypass with sleeve an effective alternative to Roux en Y gastric 
bypass in morbidly obese patients: preliminary results of a randomized trial. Obes Surg. 
2012;22(3):422-6. 
125. Kasama K, Tagaya N, Kanehira E, Oshiro T, Seki Y, Kinouchi M, et al. Laparoscopic 
sleeve gastrectomy with duodenojejunal bypass: technique and preliminary results. Obes Surg. 
2009;19(10):1341-5. 
126. Navarrete SA, Leyba JL, Llopis SN. Laparoscopic sleeve gastrectomy with 
duodenojejunal bypass for the treatment of type 2 diabetes in non-obese patients: technique 
and preliminary results. Obes Surg. 2011;21(5):663-7. 
127. Buchwald H, Kellogg TA, Leslie DB, Ikramuddin S. Duodenal switch operative 
mortality and morbidity are not impacted by body mass index. Ann Surg. 2008;248(4):541-8. 
Chapter 1: Introduction 
40 
 
128. Parikh MS, Shen R, Weiner M, Siegel N, Ren CJ. Laparoscopic bariatric surgery in 
super-obese patients (BMI>50) is safe and effective: a review of 332 patients. Obes Surg. 
2005;15(6):858-63. 
129. Fried M, Yumuk V, Oppert JM, Scopinaro N, Torres A, Weiner R, et al. 
Interdisciplinary European guidelines on metabolic and bariatric surgery. Obes Surg. 
2014;24(1):42-55. 
130. Sharman MJ, Breslin MC, Kuzminov A, Palmer AJ, Blizzard L, Hensher M, et al. 
Population estimates and characteristics of Australians potentially eligible for bariatric surgery: 
findings from the 2011-13 Australian Health Survey. Aust Health Rev. 2017;42:429-37. 
131. Sharman MJ, Hensher M, Wilkinson S, Campbell JA, Venn AJ. Review of Publicly-
Funded Bariatric Surgery Policy in Australia-Lessons for More Comprehensive Policy 
Making. Obes Surg. 2016;26(4):817-24. 
132. Brethauer SA, Kothari S, Sudan R, Williams B, English WJ, Brengman M, et al. 
Systematic review on reoperative bariatric surgery: American Society for Metabolic and 
Bariatric Surgery Revision Task Force. Surg Obes Relat Dis. 2014;10(5):952-72. 
133. Shimizu H, Annaberdyev S, Motamarry I, Kroh M, Schauer PR, Brethauer SA. 
Revisional bariatric surgery for unsuccessful weight loss and complications. Obes Surg. 
2013;23(11):1766-73. 
134. Hallowell PT, Stellato TA, Yao DA, Robinson A, Schuster MM, Graf KN. Should 
bariatric revisional surgery be avoided secondary to increased morbidity and mortality? Am J 
Surg. 2009;197(3):391-6. 
135. Inabnet WB, 3rd, Belle SH, Bessler M, Courcoulas A, Dellinger P, Garcia L, et al. 
Comparison of 30-day outcomes after non-LapBand primary and revisional bariatric surgical 
procedures from the Longitudinal Assessment of Bariatric Surgery study. Surg Obes Relat Dis. 
2010;6(1):22-30. 
Chapter 1: Introduction 
41 
 
136. Australian Institute of Health and Welfare. Weight loss surgery in Australia 2014–15: 
Australian hospital statistics. Cat. no. HSE 186. Canberra: AIHW; 2017. 
137. Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 
2013;23(4):427-36. 
138. Australian Institute of Health and Welfare. Elective surgery waiting times 2016–17: 
Australian hospital statistics. Health services series no. 82. Cat. no. HSE 197. Canberra: AIHW; 
2017. 
 
Chapter 2: Public hospital admissions for patients wait-listed for public bariatric surgery 
in Tasmania, Australia: a statewide cohort study 
 
42 
Chapter 2: Public hospital admissions for patients wait-listed for public bariatric 
surgery in Tasmania, Australia: a statewide cohort study 
Abstract 
Background: Increased demand for public bariatric surgery can create prolonged wait-
list times and may increase the burden on public healthcare. The long-term influence of bariatric 
surgery on hospital admissions is under-investigated.  
Aims: To determine public hospital service use in the form of hospital admissions and 
days in hospital per year in patients wait-listed for bariatric surgery before and after surgery or 
wait-list removal. 
Methods: All Tasmanians waiting for publicly funded primary bariatric surgery from 
2008 to 2013 and their hospital admissions between 2006 and 2014 were identified and data 
extracted using administrative datasets and medical records. Admissions were assigned to three 
periods: before wait-list, while waiting, and after a bariatric operation or drop-out. A negative 
binomial regression mixed effect model was used to compare incidence rate ratios (IRR) of 
hospital admissions and days in hospital per year during different observation periods and across 
patient groups (operated, dropped-out and waiting), adjusting for age, sex and non-independent 
observation periods. 
Results: 652 patients had 2,541 public hospital admission events. 178 patients had 
publicly funded laparoscopic adjustable gastric banding (LAGB), and 236 patients were removed 
from the wait-list without surgery. Dropped-out patients were on average older at wait-list 
placement (46.6±12.6 years) than the operated group (42.9±11.1), p<0.05 and had more days in 
hospital per year (IRR 2.22, 95% CI 1.36–3.61) while on the wait-list. Hospital admission rates 
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did not increase post-surgery (IRR 1.08, 95% CI 0.83–1.41) but days admitted per year did 
increase (IRR 1.53, 95% CI 1.01–2.34).  
Conclusions: Among patients wait-listed for publicly funded bariatric surgery in 
Tasmania, those who were younger and had fewer days in hospital per year were more likely to 
have publicly funded LAGB surgery than those who dropped-out of the wait-list. Whilst LAGB 
surgery has many health benefits, it was associated with more days in hospital per year and not 
associated with fewer public hospital admissions in the first three years of follow-up. 
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Overweight and obesity affect approximately 63% of Australian adults [1]. Over 800,000 
(26% of adults) are potentially eligible for bariatric surgery according to existing national 
guidelines based on body mass index (BMI) and comorbidities [2, 3]. Australia has universal 
healthcare (Medicare) that subsidises health costs for all citizens and permanent residents and 
provides free treatment in public hospitals. Private healthcare co-exists with the public system 
and is accessed by individuals with private health insurance or who self-fund. In some instances, 
patients may access both the public and private systems in the course of receiving treatment. 
More than 50% of all surgical procedures in Australia are performed in the private sector, with 
significantly shorter waiting times than in the public system [4]. Bariatric surgery in Australia is 
performed in both the public and private systems, although the majority of primary procedures 
are performed in private hospitals (92% of those captured in the BSR) [5], with waiting times of 
typically weeks or months rather than years. We have previously estimated that 46% of those 
eligible for bariatric surgery in Australia do not have private insurance [3], highlighting the 
potential unmet demand for publicly funded surgery. 
In Australia, it is recommended that public patients wait no longer than one year for 
elective surgery [6]. However, Tasmania has had high proportions of patients waiting for longer 
than one year in the public system (8.7%–15.5% for all types of elective surgical procedures 
compared with 1.8%–3.4% for the whole of Australia in 2008–2016 [6, 7] and 78.3% for bariatric 
surgery in 2016 [8]). When demand exceeds the capacity to provide bariatric surgery, patients 
may experience long wait times, and some patients may even die before receiving surgery [9, 
10].  
Few studies have investigated the influence of prolonged wait-list times on comorbidities 
and patients’ well-being, with most studies coming from Canada [10-13]. When surveyed, wait-
Chapter 2: Public hospital admissions for patients wait-listed for public bariatric surgery 
in Tasmania, Australia: a statewide cohort study 
 
45 
listed patients state that with prolonged wait times their physical symptoms worsen, and they 
gain weight and find the experience of waiting emotionally difficult [12, 14]. Patient drop-out 
from non-compliance with bariatric surgery program requirements and self-removal from 
programs also increase with waiting time [15]. The studies, however, focussed on the negative 
impact of prolonged waiting times on patients, leaving a gap in understanding of the impact on 
public health service use. 
The Australian experience shows that obesity is associated with higher consumption of 
health services and expenditures. For patients with a BMI over 35, health expenditures are, on 
average, 51% higher than for those of normal weight, with costs elevated for all types of medical 
care (inpatient, emergency and outpatient) and a higher probability of having any expenditure in 
inpatient and emergency settings in both the public and private systems [16]. Despite the different 
approaches to economic evaluations [17], there is evidence that bariatric surgery can result in 
life-long cost-savings [18-20], indicating that delaying surgery could possibly decrease savings 
and quality-adjusted life-year benefits. Moreover, for certain conditions, such as type 2 diabetes 
mellitus (T2DM), early bariatric surgery brings greater health benefits than when surgery is 
delayed [21]. However, even if bariatric surgery can produce savings for the healthcare system 
in the long run, it does not necessarily reduce the burden for public healthcare, as rates of hospital 
admissions after bariatric surgery can increase, especially for acute presentations relating to 
surgical complications, conditions linked to severe obesity such as gallstones, or alcohol and 
substance abuse [22]. Admissions for reasons such as total joint arthroplasty may increase after 
bariatric surgery as patients lose weight and are considered more suitable candidates [23].  
Besides costs, public hospital service use directly influences hospital capacity, which 
when strained and overcrowded is associated with poor health outcomes and increased mortality 
[24, 25]. Overall, the impact of bariatric surgery on public hospital service use and hospital 
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admissions in particular is not clear in the long term. Patients also consume healthcare resources 
while on the wait-list, and little is known about what happens to patients who are removed from 
the wait-lists without receiving bariatric surgery. 
In this retrospective statewide cohort study, we aimed to evaluate public hospital service 
use by all bariatric patients wait-listed for primary public bariatric surgery in Tasmania through 
an investigation and description of public hospital admissions before wait-list placement, while 
waiting, and after removal from the wait-list. Patients were classified according to their wait-list 
status at the end of the study period, i.e., operated, dropped-out or waiting. It was hypothesised 
that (a) beyond the immediate postoperative period, those undergoing public bariatric surgery 
would have lower rates of public hospital admissions and lower rates of days admitted than before 
surgery as their health improved; and (b) patients wait-listed for public bariatric surgery but not 
receiving it (dropped-out from the wait-list) would have increasing rates of public hospital 
admissions over time. 
2.2 Materials and methods 
This is a retrospective statewide cohort study of all patients who were on the public 
bariatric surgery wait-list in Tasmania from January 1, 2008 to December 31, 2013 to determine 
rates of public hospital admissions prior to being placed on the wait-list, while patients were 
waiting for surgery, and after surgery or drop-out of the waiting list. Admissions were ascertained 
from administrative data with look-back to May 1, 2006 and follow-up to December 31, 2014, 
or date of death, whichever was soonest. Patients were referred for bariatric surgery following 
unsuccessful management of obesity and related comorbidities and placed on the wait-list after 
a surgical consultation. During the study period, there were no mandatory preoperative weight 
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loss requirements or bariatric-surgery preparation after being placed on the wait-list, and once on 
the wait-list, patients were considered ready for surgery.  
All patients appearing on the public wait-list for bariatric surgery in Tasmania during 
2008–2013 were identified using three administrative databases kept by the state government’s 
Department of Health and Human Services to manage public wait-lists; it was not a single 
database due to system upgrades and re-organisation in the state health services over the sampling 
period. Wait-listed patients were recorded at discrete time-points (census dates), at which time 
the wait-lists were updated, and patients were either removed or retained. There was no period 
with more than three months between census points, which ensured that patients wait-listed and 
operated in the same year were not lost for sampling. Lists were updated with removal of patients 
who had received surgery in the public system, who the surgeon deemed ineligible, or who 
elected to be withdrawn (including a possibility of being already operated in the private sector). 
Letters were sent to wait-list patients annually to determine whether or not they wished to remain 
on the wait-list. Patients who were no longer contactable were also removed from the wait-list. 
In total 776 patients placed on the wait-list for bariatric surgery were identified during the 
selected period. 
Hospital admission details for all inpatient facilities in the state during the 2006–2014 
period were extracted from administrative databases for all identified patients. To ensure the 
quality of data, additional manual data extraction from the hospital digital medical records was 
performed for all hospital admissions and verified against the administrative database entries. 
This identified four placements that were not for bariatric surgery and 25 out of the study period 
due to coding errors in the original databases. Hospital admission notes were checked for 
operation details, and 95 patients who had revisional bariatric surgery following their first wait-
list entry were excluded, leaving 652 patients (Figure 10). In total 5820 admission records for 
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652 patients were identified, of which 2700 same-day admissions for haemodialysis were 
excluded as they belonged to a single patient, skewing data significantly. 
According to their wait-list status at the end of the study period, patients were classified 
as operated, dropped-out or waiting. The dropped-out group included those who were removed 
from the wait-list by the surgeon, and those who elected to be removed, were not contactable or 
died. Patients who died before the end of 2014 were followed up to their date of death within 
their allocated group (operated or dropped-out). For patients who disappeared from the wait-list 
but were not actively removed, only waiting periods prior to the last census date were included 
in the analysis to ensure the validity of the observation period. 
Three periods were identified during 2006–2014: (1) prior to being placed on the wait-
list (pre-wait-list), (2) while on the wait-list for the primary procedure, and (3) no longer waiting 
following a primary procedure or through removal from the wait-list (post-wait-list). All patients 
were observed from May 1, 2006 to December 31, 2014 or until death, whichever came first. 
Additionally, all wait-listed patients were linked to Tasmanian death registrations to ensure the 
validity of observation dates. 
Data on the wait-list entries included date of placement, date of removal and removal 
reason. Data on hospital admissions included dates of admission and discharge, anthropometric 
data (where available), hospital, unit, ICD-10AM primary diagnosis, ICD-10AM procedures, 
Australian-refined diagnosis related group (ARDRG) and major diagnostic category (MDC).  
Where available, anthropometric data were extracted from medical records, however, 
record keeping was suboptimal and too few extracted values did not allow us to perform analysis 
of weight and BMI changes over time. 
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Figure 10. Patient selection flowchart  
When calculating admission rates and lengths of stay, primary bariatric procedures were 
excluded, as well as admissions for cancelled or postponed bariatric procedures. Interfacility 
transfers were counted as single admissions. Total admission rates were calculated including 
observation time of persons without any admissions during the study period. Observation time 
for admission rates did not include in-patient time, as patients were not at risk for admission 
while being in-patients. When calculating number of days in hospital to an observation period, if 
a patient was placed on the wait-list or removed from it while being admitted, all in-hospitals 
days were attributed to the earlier observation period whichever was earlier. 
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A negative binomial mixed-effect regression model of hospital admissions and lengths of 
stay was used to compare differences between study periods and patient groups. A mixed-effect 
model with a random intercept for participant was applied because the study periods were not 
independent. Incidence rate ratios (IRR) with 95% confidence intervals (CI) were estimated by 
including an offset in the model – log of days at risk for each period – and the model was adjusted 
for sex and age at the beginning of each period. Model fit was ensured with deviance residuals 
check. Adjusted incidence rate ratios were compared between periods with the wait-list period 
used as reference, and between groups with the operated group as reference. 
Differences between patient characteristics were compared using the t-test and the χ2 test. 
P-values less than 0.05 were considered statistically significant. Statistical analysis was 
performed using Stata 14.2 software. 
2.3 Results 
2.3.1 Patient characteristics 
Of the 652 patients included in the study, 342 had already been on the wait-list prior to 
2008. By the end of the study period, 178 (27.3%) were operated on, 236 (36.2%) were removed 
from the wait-list without operation (dropped-out). 
For 109 of 178 operated-on patients, details on the type of surgery performed were 
extracted from the medical records; all had laparoscopic adjustable gastric banding (LAGB). The 
remainder of the procedures were outsourced to private hospitals (although funded by the public 
system), and the surgery type was not recorded in the health department’s database. However, 
all the outsourced procedures were performed by a single surgeon, who confirmed that LAGB 
was the only type of procedure performed for publicly funded patients. 
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Patient groups did not differ by sex and Aboriginal status. Average age at wait-list 
placement was younger in the operated than the dropped-out group (42.9 vs 46.6 years, p<0.05). 
The mean total observation period was 8.6±0.4 years for the operated group and 8.2±1.3 years 
for the dropped-out group (p<0.001). Mean follow-up time after removal from the wait-list was 
3.1±1.8 years for operated-on patients (i.e., post-op period) and 2.5±1.3 years for dropped-out 
patients (p<0.001). The patient characteristics are presented in Table 3. 
Table 3. Patient characteristics (statistically significant differences are highlighted in bold). 
 Operated* 
(n = 178) 
Dropped-out†  
(n = 236) 
Waiting‡ 
(n = 238) 
Total  
(n=652) 
Age at time of wait-list (WL) 
placement, years (SD) 
42.9 ± 11.1 46.6 ± 12.6 43.9±12.0 44.6±12.1 
Males, % (n) 24 (43/178) 31 (73/236) 26 (62/238) 27 (178/652) 
Aboriginal or Torres Strait 
Islander origin, % (n) 
6.3 (9/143) 10.6 (23/217) 6.5 (8/124) 7.4 (40/484) 
Weight at time of WL placement 
(n), kg 




BMI at time of WL placement (n) 44.0±7.6 (16) 45.3±6.8 (16) 45.6±8.8 (19) 45.0±7.7 (51) 
Weight at time of WL removal 
(n), kg 
139.8±29.8 (89) 118.1±25.5 (39) n/a 133.2±30.2 (128) 
BMI at time of WL removal (n) 49.6±9.4 (89) 44.1±8.6 (22) n/a 48.6±9.4 (111) 
Average waiting time, years 4.1±2.8 4.5±2.4 4.4±2.6 4.4±2.6 
Observation time prior to WL 
placement, years 
2.6±1.8 2.5±1.6 2.6±1.9 1.9±1.9 
Observation time during WL 
period, years 
3.5±2.1 4.0±1.9 4.0±2.6 3.9±2.2 
Observation time after removal 
from WL, years 
3.1±1.8 2.5±1.3 n/a 2.7±1.7 
Total observation time, years 8.6±0.4 8.2±1.3 6.1±3.0 7.5±2.3 
* Patients who had bariatric surgery. 
† Patients removed from the wait-list without operation. 
‡ Patients remaining on the wait-list at the end of the study period. Those with the unknown status accounted only for their 
known waiting time 
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After excluding admissions for bariatric surgery and dealing with interfacility transfers, 
2,541 admission events were analysed. 
2.3.2 Hospital admission rates 
Prior to being placed on the wait-list, the overall rate of hospital admissions was 49.0 per 
100 person-years: 42.5 in the operated group and 56.3 in the dropped-out group. While on the 
wait-list, overall admission rates were similar to those observed for patients prior to their wait-
list placement (42.7 and 58.6 admissions per 100 person-years for operated and dropped-out 
group respectively). After surgery the unadjusted admission rate increased to 61.6 per 100 
person-years, while after drop-out from the wait-list it remained at the level 58.5 admissions per 
100 person-years. Unadjusted hospital admission rates are summarised in Table 4. 
When comparing IRR adjusted for age, sex and non-independent observation periods 
within participants, there was no significant difference between groups and periods ( 
Table 5). 
Figure 11 demonstrates yearly changes in admission rates in relation to the wait-list 
removal date. An initial increase in admission rates post-surgery can be seen with a peak in the 
second year, and subsequent decrease in the third year (IRR between the third and the second 
year 0.61, 95% CI 0.38–0.98). 
Table 4. Public hospital admission rates (unadjusted) per 100 person-years 
Wait-list status Pre wait-list On wait-list Post wait-list Total 
Operated 42.5 42.7 61.6 49.6 
Dropped-out 56.3 58.6 58.5 58.0 
Waiting/Unknown 46.8 45.6 n/a 46.0 
Total 49.2 49.7 60.1 51.9 
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Pre wait-list On wait-list Post wait-list 
 IRR between groups 
Operated 1 1 1 
Dropped-out 1.01 (0.86–1.49) 1.26 (0.92–1.72) 1.07 (0.78–1.50) 
Waiting 0.88 (0.59–1.31) 1.02 (0.74–1.40) n/a 
 IRR between periods 
Operated 0.98 (0.71–1.34) 1 1.08 (0.83–1.41) 
Dropped-out 0.78 (0.61–1.01) 1 0.96 (0.77–1.20) 
Waiting 0.93 (0.73–1.17) 1 n/a 




Figure 11. Trends in hospital admission rates by years from wait-list removal (represented as 0) 
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2.3.3 Days in hospital per year 
Average rate of days in hospital per person-year was 1.1 in the operated group while on 
the wait-list and 2.9 in the postoperative period, while rates of days in hospital per person-year 
were 4.0 and 2.6 days in the dropped-out group while waiting and after wait-list removal 
respectively (Table 6). 
The dropped-out group patients had a higher rate of days in hospital while waiting 
compared with the operated group (IRR 2.22, 95% CI 1.36–3.61). The number of days in hospital 
per year increased for the operated-on patients after LAGB (IRR 1.53, 95% CI 1.01–2.34). 
Detailed results are presented in Table 7. 
Table 6. Days in public hospital per person-year (unadjusted) 
Wait-list status Pre wait-list On wait-list Post wait-list Total 
Operated 1.5 1.1 2.9 1.8 
Dropped-out 2.7 4.0 2.6 3.3 
Waiting/Unknown 1.5 2.4 n/a 2.1 
Total 1.9 2.7 2.8 2.5 
 




Pre wait-list On wait-list Post wait-list 
 IRR between groups 
Operated 1 1 1 
Dropped-out 1.12 (0.63–1.99) 2.22 (1.36–3.61) 1.03 (0.63–1.70) 
Waiting 0.70 (0.39–1.25) 1.43 (0.87–2.34) n/a 
 IRR between periods 
Operated 1.18 (0.73–1.90) 1 1.53 (1.01–2.34) 
Dropped-out 0.60 (0.40–0.88) 1 0.71 (0.49–1.03) 
Waiting 0.58 (0.38–0.87) 1 n/a 
*Adjusted for age, sex and non-independent observation periods. Statistically significant differences are 
highlighted in bold. 
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2.3.4 Reasons for hospital admissions 
The most common reasons for most common hospital admissions were identified using 
major diagnostic categories (Table 8) and ICD-10 codes (Table 9).  
Table 8. Admission rates (unadjusted) per 100 person-years for the most common (≥100 
admissions) major diagnostic categories (MDC)  
MDC Wait-list 
status 
Absolute numbers for 
the total period 
Admission rates per 100 py in periods 








D&D8 of the 
musculoskeletal system 
and connective tissue 
Operated 82 42 4.4 5.1 6.3 5.4 
Dropped-out 180 61 9.5 10.7 6.8 9.3 
Waiting 77 40 6.6 4.7 n/a 5.3 
D&D of the circulatory 
system 
Operated 100 41 5.6 6.7 7.0 6.5 
Dropped-out 151 62 7.5 8.1 7.7 7.8 
Waiting 51 26 2.3 4.2 n/a 3.5 
D&D of the digestive 
system 
Operated 75 41 5.6 3.8 5.7 4.9 
Dropped-out 113 63 6.1 5.2 6.8 5.9 
Waiting 83 44 5.6 5.8 n/a 5.8 
D&D of the nervous 
system 
Operated 98 29 6.8 5.7 7.0 6.4 
Dropped-out 68 38 4.3 3.5 3.0 3.5 
Waiting 40 25 3.5 2.4 n/a 2.8 
D&D of the skin, 
subcutaneous tissue and 
breast 
Operated 77 29 3.8 4.0 7.0 5.0 
Dropped-out 70 38 3.4 4.0 3.2 3.6 
Waiting 57 31 3.1 4.4 n/a 4.0 
D&D of the respiratory 
system 
Operated 38 23 3.0 2.4 2.3 2.5 
Dropped-out 73 42 2.9 3.3 5.5 3.8 
Waiting 84 24 7.0 5.2 n/a 5.8 
Factors influencing health 
status and other contacts 
with health services 
Operated 32 23 1.8 0.8 3.8 2.1 
Dropped-out 74 39 3.2 4.2 3.8 3.8 
Waiting 50 19 3.3 3.6 n/a 3.5 
Mental D&D 
Operated 35 9 0.3 3.0 2.7 2.3 
Dropped-out 83 14 4.8 4.1 4.3 4.3 
Waiting 20 4 1.7 1.3 n/a 1.4 
D&D of the female 
reproductive system† 
Operated 37 21 2.7 3.9 3.2 3.0 
Dropped-out 51 31 3.9 6.8 3.8 3.3 
Waiting 38 24 3.6 n/a 3.6 3.5 
Injuries, poisoning and 
toxic effects of drugs 
Operated 44 32 0.9 0.6 6.6 2.9 
Dropped-out 49 29 3.2 2.4 2.3 2.5 
Waiting 18 11 1.2 1.3 n/a 1.2 
D&D of the kidney and 
urinary tract 
Operated 25 11 0.3 1.1 3.0 1.6 
Dropped-out 60 29 3.6 2.8 3.2 3.1 
Waiting 23 11 1.2 1.8 n/a 1.6 
Pregnancy, childbirth and 
the puerperium† 
Operated 28 10 4.9 0.6 2.9 2.4 
Dropped-out 38 17 3.6 2.8 2.2 2.8 
Waiting 34 10 4.4 2.6 n/a 3.2 
* D&D - diseases and disorders 
†Calculated for female patient person-time only 
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Table 9. Admission rates per 100 person-years for the most common (≥30 patients) primary 
ICD-10-AM diagnoses 
Primary diagnosis Wait-list 
status 
Absolute numbers for 









Operated 34 25 1.5 3.0 1.8 2.2 
Dropped-out 26 19 1.8 1.2 1.3 1.3 
Waiting 18 15 1.4 1.1 n/a 1.2 
Type 2 diabetes 
Operated 16 12 1.8 0.8 0.9 1.0 
Dropped-out 18 23 1.6 2.6 1.1 2.0 
Waiting 12 5 0.8 0.8 n/a 0.8 
Cellulitis 
Operated 37 13 2.1 2.1 3.0 2.4 
Dropped-out 26 15 2.3 0.8 1.5 1.3 
Waiting 11 7 0.2 1.0 n/a 0.8 
Abdominal pain 
Operated 13 11 0.6 0.8 1.1 0.9 
Dropped-out 20 14 1.6 0.6 1.3 1.0 
Waiting 10 9 0.6 0.7 n/a 0.7 
Cholelithiasis 
Operated 15 11 1.5 0.6 1.1 1.0 
Dropped-out 18 13 0.9 0.8 1.1 0.9 
Waiting 8 8 0.8 0.4 n/a 0.6 
Gonarthritis 
Operated 15 11 1.5 0.5 1.3 1.0 
Dropped-out 18 15 1.4 1.0 0.4 0.9 
Waiting 8 6 0.8 0.4 n/a 0.6 
Carpal tunnel 
syndrome 
Operated 12 8 1.5 0.8 0.4 0.8 
Dropped-out 17 13 1.1 0.9 0.6 0.9 
Waiting 11 8 0.4 0.9 n/a 0.8 
 
However, the study was underpowered to derive incidence rate ratios for groups and 
period comparisons using the adjusted mixed-effect model, so the data is presented for 
completeness and descriptive purposes. Compared with the operated-on group, the dropped-out 
group had higher rate of admissions for mental disorders before being placed on the wait-list (0.3 
vs 4.8 admissions per 100 person-years), and for obstetrics causes and injuries, poisonings and 
drug intoxications while on the wait-list (0.6 vs 2.8 and 0.6 vs 2.4 admissions per 100 person-
years respectively). After the surgery, there was an increase in admission rates for injuries, 
poisonings and intoxications (0.6 to 6.6 admissions per 100 person-years), and for pregnancy and 
childbirth (0.6 to 2.9 admissions per 100 person-years). Differences in other reasons for 
admissions between groups and periods were of less magnitude. 
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Our study revealed that performing bariatric surgery as LAGB for public patients did not 
change the average rate of public hospital admission rates in the follow-up period of three years. 
This result is consistent with findings describing high rates of postoperative admission over 2 
years [26] and is supported by reports of increasing postoperative admission rates for certain 
conditions [22, 27]. A recent Western Australian study found that overall admission rates 
decreased along with a significant increase in admissions for gastrointestinal causes [28]. In our 
study, a peak of admissions occurred during the first two years after the operation with a 
decreasing trend thereafter, possibly reflecting admissions for LAGB-related problems initially 
and suggesting that admission rates could decrease with prolonged follow-up and health status 
improvement due to weight loss. 
LAGB was also the most commonly revised surgery in Australia during the study period 
[8], and conditions ultimately leading to the need of revision could also contribute to admissions 
in the post-operative period. 
While we were not able to derive adjusted hospital admission rate ratios by MDC, and 
cannot state that there was a statistically significant difference in rates of admissions for different 
reasons, we noticed differences in admission rates for certain causes between groups and among 
periods. While the data do not provide sufficient evidence of higher drop-out among patients 
with admissions for psychiatric admissions, it is plausible that surgeons do not select these 
patients for surgery because a number of untreated psychiatric conditions are considered to be 
contraindications to bariatric surgery [29]. Higher rates of admissions for obstetric causes post-
surgery could be related to improved fertility with weight loss. Also patients who got pregnant 
while on the wait-list could be dropped-out or postponed`, as rapid weight loss is not 
recommended during pregnancy [30], leaving those with lower pregnancy rates to undergo 
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surgery. The causative link, however, should be investigated in further studies with higher 
number of participants. 
This study is the first to report on the public hospital burden in relation to bariatric surgery 
measured in hospital stay days per person-year. We noticed a postoperative increase in days of 
hospital stay per year. This could be related to the increased complexity of patients post bariatric 
surgery or might reflect greater caution or additional investigations.We also discovered that 
patients who had bariatric surgery had lower rates of days of hospital stay in public inpatient 
facilities while on the wait-list than those who dropped-out.  
A higher rate of days spent in hospitals per year in the dropped-out group may have 
reflected health conditions that were contraindications for surgery. We note that the Edmonton 
Obesity Score System [31] acknowledges severe obesity-related comorbidities as a possible 
indication for palliative measures rather than surgery, but it is unclear from the literature how 
often patients are diverted from bariatric surgery once placed on a wait-list. It is not clear why 
there was a trend towards prioritisation of younger patients. 
Our literature search did not identify any similar studies comparing wait-list times in 
operated and dropped-out groups, although a previous study suggested an association between 
prolonged waiting time and attrition from bariatric surgery [15]. This finding was not supported 
by our study, which found no significant difference between those groups. 
Among this study’s strengths, is that it included all public wait-listed patients in the state, 
making it free of selection bias. We established a long observation period encompassing both 
time prior to placement on the wait-list and while waiting for surgery, with an average of more 
than five years in the preoperative period and three years postoperatively. This period of 
observation is similar to or greater than those of other cohort studies reporting admission rates 
[22, 26, 27]. Patients who were wait-listed for bariatric surgery but dropped-out were used as a 
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comparison group rather than a matched sample of general public patients, thereby decreasing 
the differences between the groups in terms of obesity and its comorbidities. 
There are certain limitations of this study, which describes the population of a single state 
with a small number of surgeons performing bariatric operations, most of these being LAGB. 
LAGB is still the most commonly performed bariatric surgery in Tasmania, in contrast to trends 
elsewhere in Australia and around the world [32]. Post-operative follow-up with outpatient visits 
was out of the scope of this study, but variability in follow-up quality could influence hospital 
admission rates within the operated group. We cannot comment on hospital admission rates 
beyond an average of three years. We were also limited by the scope of administrative data for 
public patients and could not include private hospital admissions for patients who may have used 
both health systems. Some admissions might have been missed if patients left Tasmania or 
travelled interstate for healthcare. While the administrative data used to define eligible patients 
and their hospital admissions were adequate, the information in individual medical records was 
frequently incomplete, especially for patients who dropped-out from the wait-list, and hence, we 
could not include in our analysis variables such as weight and BMI. 
While drop-out without having publicly funded bariatric surgery did not lead to an 
increase in rates of public hospital admissions and days in hospital per year, we caution against 
interpretation of the findings of increasing in-hospital stay burden for operated-on patients as 
negative for the public health system. When a hospital adds a surgical intervention to its scope 
of practice, the allocated resources must include long-term management of the condition in 
addition to the initial costs related to the procedure. The introduction of procedures with proven 
individual benefits into public hospitals is justified when the consequences of not treating a 
condition may be catastrophic for the individual. Moreover, the in-hospital length of stay, 
although a proxy for hospital costs, misses many costs that may be borne by the community, e.g., 
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by the individual and their family, loss of productivity, or other community and health services. 
A treatment that saves costs for a community while transferring some costs into the hospital 
system may be justifiable if the community savings and well-being gain are sufficient. We think 
that further development of existing bariatric surgery eligibility and prioritisation guidelines will 
allow for better selection of patients who might benefit most from bariatric surgery and 
simultaneously reduce the demand on the public health system. 
2.5 Conclusion 
We conclude that (i) patients with a lower number of days in hospital per year, i.e., 
healthier patients, and younger patients were more likely to receive bariatric surgery in this high-
demand setting; (ii) patients who received bariatric surgery did not have a significantly increased 
rate of hospital admissions during an average of three years after publicly performed LAGB 
compared with the wait-list period; (iii) while the rate of admissions did not change significantly 
after the surgery, hospital stay burden reflected as days in hospital per person-year increased after 
LAGB in the three year observation period; and (iv) drop-out of the wait-list for publicly funded 
bariatric surgery was associated with increased number of days in hospital per year, but not with 
an increased rate of hospital admissions while on the wait-list.  
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Chapter 3: Rates and reasons for emergency department presentations of 
patients wait-listed for public bariatric surgery in Tasmania, Australia 
Abstract 
Background: Demand for bariatric surgery in the public hospital setting in Australia is 
high with prolonged wait-list times. Policy-makers need to consider the consequences of 
expanding public bariatric surgery including on emergency department (ED) presentations. 
Aims: to describe and evaluate public ED presentation rates and reasons for presenting 
in a cohort of patients wait-listed for public surgery.  
Methods: all Tasmanians placed on the public wait-list for primary bariatric surgery in 
2008–2013 were identified using administrative datasets along with their ED presentations in 
2000–2014. The presentations were assigned to one of three periods: before wait-list 
placement, whilst on the wait-list, and after wait-list removal for publicly funded surgery or 
drop-out. A negative binomial mixed-effects regression model was used to derive ED 
presentation incidence rate ratios (IRR) to compare observation periods and patient groups. 
Results: 652 wait-listed patients had 5,149 public ED presentations. 178 patients had 
publicly funded bariatric surgery – all as laparoscopically adjustable gastric banding (LAGB). 
Overall, ED presentation rates did not change significantly post-surgery compared with the 
waiting period (IRR 1.19, 95% CI 0.90–1.56). Presentation rates significantly increased for 
digestive system (IRR 2.02, 95% CI 1.19–3.45) and psychiatric diseases (IRR 4.85, 95% CI 
1.06–22.26) after surgery. The likelihood of being admitted from the ED significantly increased 
after surgery (31.7% to 38.9%, p<0.05).  
Conclusion: ED presentations were common for patients wait-listed for public bariatric 
surgery and rates did not decrease over an average of three years post-LAGB. The likelihood 
of being admitted to the hospital from the ED increased after surgery.  
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Bariatric surgery is currently the most effective treatment for resistant obesity and 
obesity-related diseases and is recommended for patients with severe obesity or obesity-related 
comorbidities and type 2 diabetes (T2DM) [1]. Its cost-effectiveness, however, remains 
unclear. Some studies have shown economic benefits, with reductions in healthcare costs, 
whereas others have demonstrated increased total costs in operated groups [2-4]. Studies have 
reported on patient cohorts with different health insurance status and in different healthcare 
systems [5], making comparisons difficult. 
This uncertainty remains for not only healthcare costs but also the utilisation of 
healthcare facilities including through hospital admissions and emergency department (ED) 
presentations. Our study of hospital admissions in the Tasmanian public system demonstrated 
that admission rates did not decrease during three years of follow-up post-surgery and even 
increased in the first two years, with a decreasing trend thereafter (Chapter 2). Some studies 
have demonstrated that in-hospital service use decreased post-operation [6], especially for 
certain comorbidities [7, 8], whereas other authors have suggested that surgery increased in-
hospital demands and acute presentations, especially in the first 30 days after the operation or 
during short-term follow-up [9].  
It is unclear from the available literature whether bariatric surgery significantly 
influences rates and reasons for presentations to emergency departments in the long-term. 
During a 4-year follow-up of 174 obese patients in Brazil, emergency service use after bariatric 
surgery was not higher than in a non-operated obese population [10]. Nevertheless, in the 
majority of studies, including a longitudinal analysis of administrative data focused on short-
term outcomes and re-presentations [11], postoperative emergency department presentation 
rates after Roux-en-Y gastric bypass (RYGB) [12] or a mix of procedures (RYGB, duodenal 
switch, gastric plication) [13] increased compared with the preoperative period and were more 
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likely to be surgery-related. In a UK hospital, operated-on patients presented to emergency 
departments with surgery-related complications up to two years post-surgery [14].  
ED presentations post-surgery do not necessarily indicate postoperative complications 
and are often referred to as undifferentiated abdominal pain, nausea or vomiting [15, 16] that 
may reflect difficulties in adjusting to lifestyle and dietary changes after surgery [17]. Such 
presentations, even if not leading to hospital admissions, still utilise public healthcare 
resources. ED presentations that lead to hospital admission increase resource use even more. 
The likelihood of being admitted after presentation to the ED differs greatly among studies 
(32–85%), depending on the type of bariatric procedure, whether the procedure was performed 
in the same hospital, whether the centre was compliant with optimal practice policies, and 
overall bariatric centre complication rates [15, 18, 19]. 
Insurance status also influences the risk of presentation to the ED post bariatric surgery 
with patients with private insurance presenting less often in a study from the United States [18]. 
In Australia, most bariatric procedures are performed in the private sector (88% according to 
the data captured by the BSR in 2017) [20], although more than 400,000 uninsured Australians 
may be eligible for bariatric surgery [21]. In this setting, policy-makers need to consider the 
range of resources required for the treatment of bariatric patients in the publicly funded health 
system.  
When waiting for bariatric surgery for a prolonged time, patients experience worsening 
of their physical symptoms and increase in their weight [22, 23], that could potentially 
influence the ED presentation rate, however, this was not previously investigated. We 
hypothesised that the rates and reasons for ED presentations would increase while waiting for 
bariatric surgery and after receiving it. This study aimed to describe and compare the 
frequency, reasons and outcomes of public hospital ED presentations for all patients wait-listed 
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for bariatric surgery in the Tasmanian public sector over a ten-year period, according to their 
wait-list status and outcome.  
3.2 Materials and methods 
This is a retrospective statewide cohort study of public ED presentations during the 
period 2000–2014 of all patients appearing on the public wait-list for primary bariatric surgery 
in the sampling period 2008–2013.  
Tasmania has three main public hospitals and a number of additional small inpatient 
facilities. All public bariatric surgery in Tasmania is conducted in two public hospitals. All 
patients waiting for public bariatric surgery in Tasmania during 2008–2013 were identified 
using three administrative databases (multiple databases were used due to the migration of data 
to new systems over time and due to structural changes within the Department of Health). All 
databases used certain repetitive time points called “census dates”, ranging from monthly to 
annually (depending on the database used) to represent patients’ progress on the wait-list and 
to ensure that patients remained on the wait-list. To achieve this, patients received annual letters 
in response to which they had to confirm whether they still required and wished to receive 
surgery. Patients were placed on the wait-list after a surgical consultation following a GP 
referral when conservative treatment was considered ineffective. There were no mandatory 
requirements for patients to achieve and/or maintain certain weight loss or otherwise 
demonstrate compliance after being placed on the wait-list. Patients were removed from the 
wait-list after undergoing surgery, after submitting a response letter indicating that they did not 
want or did not require surgery, or after not engaging in correspondence. 
We identified 776 patients appearing on wait-lists for bariatric surgery in the selected 
timeframe. Data on ED presentations in 2000–2014 were extracted from an administrative 
database. These data included ED presentation dates, ICD-10 diagnostic codes, and urgency 
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related group major diagnostic block categories (URG MDB), and outcomes (admission or 
discharge).  
Additional manual data extraction from digital medical records was performed for all 
the patients identified to ascertain hospital admissions in all inpatient facilities in 2006–2014, 
to obtain bariatric surgery type and whether it was primary or revisional, and to extract 
anthropometric data where available. After this process, 124 patients were excluded: 4 were 
identified as being on the wait-list for non-bariatric surgery, for 25 patients the wait-list dates 
were outside the study timeframe (removed before 2008 or placed after 2013), and 95 patients 
had had previous bariatric surgery, and therefore did not meet the inclusion criteria.  
In total, 652 patients were included as wait-listed for primary bariatric surgery in 
Tasmania in 2008–2013 (Figure 12). Patients waiting for bariatric surgery were divided into 
three groups depending on the waiting outcome: 1) removed from the wait-list after undergoing 
a bariatric procedure (operated), 2) removed from the wait-list without a publicly funded 
operation (dropped-out), and 3) those who were still waiting for surgery by the end of 2014, or 
had disappeared from the wait-list without being actively removed for any stated reason. 
All ED presentations were assigned to one of the periods in relation to wait-list 
placement and removal dates: 1) prior to being placed on the wait-list (pre-WL), 2) while on 
the wait-list (WL), 3) after removal from the wait-list for bariatric surgery or for other reasons 
(post-WL). Patients who disappeared from the wait-list without a record of being removed were 
followed up to their last census date (regular discrete time-points in the wait-list records) of 
being present on the wait-list. In total, 5,149 ED presentations were identified within the study 
period for the included patients. 
ED presentation rates were calculated as presentations per 100 person-years. The 
reasons for presentations were determined using URG MDB (where available) in the 
administrative data. In calculating the ED presentation rates, we accounted for possible 
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increased presentation rates immediately after surgery and excluded 30 patients with ED 
presentations within 30 days of a bariatric operation. While complications from certain bariatric 
procedures can persist beyond 30 days, our aim was not to exclude these delayed complications 
from analysis, but rather to discount generic surgical complications, that typically occur within 
30 days. We also excluded eight presentations when patients were dead on arrival to the ED. 
 
Figure 12. Patient selection flowchart 
A negative binomial mixed-effects regression model of ED presentations was used to 
compare follow-up periods and patient groups, including an interaction term between these two 
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variables. Mixed-effects regression with a random intercept for a participant was used because 
each participant had more than one (non-independent) observation period. Incidence rate ratios 
(IRR) were estimated by including an offset in the model – log of days at risk for each period 
– and the model was adjusted for sex and age at the beginning of each period. Deviance 
residuals were checked to ensure model fit. Adjusted incidence rate ratios were compared 
between periods (using the wait-list period as reference) and groups (using the operated group 
as reference). A similar model was used for annual incidence rate comparisons, with each year 
before and after removal from the wait-list being a separate period. IRRs were reported with 
95% confidence intervals (CI). 
Differences between patient characteristics in the operated and dropped-out groups 
were compared using the t-test and the χ2 test. ED presentation outcomes as proportions 
admitted to hospital were compared between the operated and dropped-out groups and 
consecutive periods (before wait-list placement, while waiting and after surgery or drop-out) 
using the χ2 test. P-values less than 0.05 were considered statistically significant. Statistical 
analysis was performed using Stata 14.2 software. 
3.3 Results 
3.3.1 Patients characteristics 
Of 652 patients waiting for primary public bariatric surgery in 2008– 2013, 178 (27.3%) 
were operated on, 236 (36.2%) were removed from the wait-list without publicly funded 
bariatric surgery, and 238 (36.5%) were still waiting or disappeared from the wait-list and were 
followed to their last census date. 
Publicly operated-on patients were, on average, younger when placed on the wait-list 
than those who dropped-out (42.9±11.1 vs 46.6±12.6 years, p<0.01). There were no significant 
differences in the proportions of males or Aboriginal patients between the groups. Incomplete 
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hospital medical records prevented comparison of patients’ weights and BMIs upon wait-list 
placement or removal. The average total observation period was 13.4±2.3 years and the average 
follow-up time was 2.8±1.6 years after being removed from the wait-list following public 
surgery or dropping-out without a publicly funded operation. The operated group had longer 
observation time post-WL removal than the dropped-out group, in which 21 patients were 
removed due to death and did not have a post-removal observation period (Table 10). 
Table 10. Patient characteristics (statistically significant differences are highlighted in bold). 
 Operated*  
(n = 178) 
Dropped-out†  
(n = 236) 
Waiting ‡ 
(n = 238) 
Total  
(n=652) 
Age at time of wait-list (WL) 
placement, years (SD) 
42.9 ± 11.1 46.6 ± 12.6 43.9±12.0 44.6±12.1 
Males, % (n) 24 (43/178) 31 (73/236) 26 (62/238) 27 (178/652) 
Aboriginal or Torres Strait 
Islander origin, % (n) 
6.3 (9/143) 10.6 (23/217) 6.5 (8/124) 7.4 (40/484) 
Weight at time of WL placement 
(n), kg 





BMI at time of WL placement (n) 44.0±7.6 (16) 45.3±6.8 (16) 45.6±8.8 (19) 45.0±7.7 (51) 
Weight at time of WL removal 
(n), kg 
139.8±29.8 (89) 118.1±25.5 (39) n/a 
133.2±30.2 
(128) 
BMI at time of WL removal (n) 49.6±9.4 (89) 44.1±8.6 (22) n/a 48.6±9.4 (111) 
Average waiting time, years 4.1±2.8 4.5±2.4 4.4±2.6 4.4±2.6 
Observation time prior to WL 
placement, years 
7.2±2.7 7.3±2.3 7.5±2.5 7.4±2.5 
Observation time during WL 
period, years 
4.1±2.8 4.5±2.4 4.4±2.6 4.4±2.6 
Observation time after removal 
from WL, years 
3.2±1.8 2.5±1.4 n/a 2.8±1.6 
Total observation time, years 14.5±0.4 14.1±1.3 11.9±3.0 13.4±2.3 
* Patients who had bariatric surgery. 
† Patients removed from the wait-list without operation. 
‡ Patients remaining on the wait-list or with unknown wait-list status at the end of the study period. Those with the unknown 
status accounted only for their known waiting time. 
 
109 of 178 patients were operated in public hospitals. We were able to identify the 
procedure performed for all of them, which was laparoscopic adjustable gastric banding 
(LAGB) in all cases. For the 69 patients who were outsourced to the private hospitals using 
public funding, we did not have access to medical records for their surgery admission with the 
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procedure details. However, all outsourced publicly funded bariatric procedures were 
performed by a single surgeon, who confirmed that LAGB was the only type of procedure 
performed for these patients. This is also supported by the Medicare Benefit Schedule data for 
the types of procedures that were performed in the private sector in the state during the study 
period, with 98.9% of procedures being LAGB. 
3.3.2 ED presentation rates 
Among all wait-listed patients, 86.2% presented to the ED at least once, with no 
significant difference between operated-on and dropped-out patients. Unadjusted ED 
presentation rates are presented in Table 11. Over 50% of patients presented to the ED four or 
more times over the observation period. 
Table 11. Public hospital ED presentation rates (unadjusted) per 100 person-years 
Wait-list status Pre wait-list On wait-list Post wait-list Total 
Operated 40.3 59.2 73.6 53.0 
Dropped-out 61.5 61.2 73.3 63.3 
Waiting 48.7 72.7 n/a 57.6 
Total 51.1 65.0 73.6 58.4 
 
Prior to being placed on the wait-list, patients in all groups had significantly lower ED 
presentation rates compared with the wait-list period (Table 12). There were no significant 
differences in ED presentation rates between groups in any period.  
When comparing the annual ED presentation rates in the year preceding surgery 
(reference period) and annually postoperatively (Figure 13), we observed initially increasing 
rates in the first two years postoperatively with a peak in the ED presentations in the second 
year (IRR 1.54, 95% CI 1.01–2.36) and a subsequent decrease after that period (IRR 1.24, 95% 
CI 0.77–2.00). 
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Table 12. Adjusted* ED presentation incidence rate ratios (IRR) with 95% confidence 
intervals 
Wait-list status Period 
Pre wait-list On wait-list Post wait-list 
 IRR between groups 
Operated 1 1 1 
Dropped-out 1.32 (0.96–1.81) 1.26 (0.91–1.76) 1.17 (0.83–1.67) 
Waiting 1.07 (0.78–1.46) 1.23 (0.88–1.71) n/a 
 IRR between periods 
Operated 0.69 (0.54–0.91) 1 1.19 (0.90–1.56) 
Dropped-out 0.73 (0.59–0.91) 1 1.10 (0.87–1.41) 
Waiting 0.61 (0.48–0.76) 1 n/a 
*Adjusted for age, sex and non-independent observation periods. Statistically significant differences are 





Figure 13. Trends in ED presentation rates by years relative to the time of wait-list removal 
(represented as 0) 
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3.3.3 ED episode outcomes 
The proportion of patients admitted to hospital after presenting to the ED increased for all 
patient groups with duration of time on the wait-list over the successive periods of follow-up 
(pre-, during and post-wait-list) (Table 13). There was no statistically significant difference 
between groups in the likelihood of being admitted following presentation to the ED prior to 
being placed on the wait-list. During the waiting period, ED presentations in the operated group 
resulted in fewer admissions compared with the dropped-out patients (31.7% vs 39.4%, 
p<0.05). After the bariatric operation, however, the likelihood of being admitted following ED 
presentation increased significantly to 38.9%, p<0.05. 
Table 13. Proportion of ED presentations admitted to hospital or transferred to another 
hospital (excluding presentations within 30 days post bariatric surgery) 
Wait-list status 
Period 
Pre wait-list On wait-list Post wait-list 
% (n) % (n) % (n) 
Operated 25.5 (131) 31.7 (140) 38.9 (162)  
Dropped-out 30.4 (324) 39.4 (255) 44.3 (174) 
Waiting 20.8 (181) 26.3 (201) n/a 
Total 26.0 (636) 32.2 (596) 41.5 (336) 
* Statistically significant differences between operated and dropped-out groups are underlined, statistically 
significant differences between consecutive periods within groups are highlighted with bold.  
 
3.3.4 Reasons for ED presentations 
While ED presentations in the first 30 days post-surgery were not included in the rate 
calculation given the inevitable increase due to immediate postoperative complications, we 
looked at the reasons for these early ED presentations (Table 14), of which 18 (60%) could be 
attributed to postoperative complications. 
According to the analysis by URG MDB, the most common cause for ED presentation 
for the overall study period was circulatory system illnesses (7.2 presentations per 100 person-
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years), and the presentation rate for this cause did not differ significantly between the waiting 
and post-waiting periods following surgery or drop-out.  
Table 14. Principal diagnoses (ICD-10AM) of ED presentations (n=30) within 30 days of the 
primary bariatric surgery 
Principal diagnosis description Number of presentations Percentage 
Unspecified complication of the procedure 5 16.7 
Wound infection following a procedure 2 6.7 
Lobar pneumonia 2 6.7 
Other and unspecified abdominal pain 2 6.7 
Attention to surgical dressings and sutures 1 3.3 
Disruption of operation wound 1 3.3 
Embolism and thrombosis of unspecified vein 1 3.3 
Postprocedural disorder of digestive system, unspecified 1 3.3 
Surgical follow-up care, unspecified 1 3.3 
Hypoglycaemia 1 3.3 
Acute stress reaction 1 3.3 
Bronchitis not specified 1 3.3 
Cervicalgia 1 3.3 
Follow-up examination after unspecified treatment 1 3.3 
Hordeolum 1 3.3 
Open wound to finger(s) 1 3.3 
Other specified abnormal uterine or vaginal bleeding 1 3.3 
Other specified disorder of teeth and support structures 1 3.3 
Other inflammatory disorders of penis 1 3.3 
Procedure not done, patient declined 1 3.3 
Superficial injury of forearm 1 3.3 
Syncope and collapse 1 3.3 
No ICD-10 code 1 3.3 
 
When the presentation rates during the wait-list time were compared with those during 
the postoperative period for the operated group, there was a significant increase in rates of 
presentations for digestive system illnesses (IRR 2.02, 95% CI 1.19–3.45). Moreover, 
compared with the dropped-out group, operated-on patients were significantly more likely to 
present to the ED with digestive system illnesses in the post-wait-list period (11.01 vs 5.41 per 
100 person-years, p<0.01). 
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In the operated group there was a significant increase in the postoperative period in 
presentations for urological system illness (1.27 to 5.68 per 100 person-years), mainly due to 
urinary tract infections in the remote period, that could not be attributed to the immediate 
postoperative catheter-related infections, or to dehydration acute kidney injury. 
The dropped-out patients tended to have a higher rate of psychiatric presentations than 
the operated group initially (pre-wait-list IRR 4.17, 95% CI 0.97–17.91) and while on the wait-
list (IRR 4.03, 95% CI 0.82–19.70). When comparing periods, for the operated-on patients ED 
presentation rates for psychiatric illnesses increased significantly after the surgery (IRR 4.85, 
95% CI 1.06–22.26).  
Details of the presentation rates by the most common URG MDB are summarised in 
Table 15. 
3.4 Discussion 
We found that rates of ED presentations increased after the wait-list placement (as 
expected for patients referred for surgical treatment of obesity compared with the earlier period 
when they did not require it), and that ED presentation rates did not decrease after publicly 
funded bariatric surgery performed as LAGB even after excluding presentations within 30 days 
of surgery. Studies comparing postoperative resource utilisation for up to four years after 
various bariatric procedures, such as LAGB, RYGB and sleeve gastrectomy, also found no 
decrease in ED visits [6, 10]. 
While there was a peak of presentations within 2 years after the surgery and an increase 
in presentations for certain conditions after the surgery, overall postoperative ED presentation 
rates were not higher compared with the dropped-out group. 
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Table 15. Adjusted* ED presentation incidence rate ratios (IRR) with 95% confidence 
intervals for the most common (≥100 presentations) urgency related group major diagnostic 




Absolute numbers for the 
total period 
Periods 
Presentations Patients Pre wait-list On wait-list Post wait-list 
Circulatory 
system illness 
Operated 172 53 0.37 (0.21–0.64) 1 0.80 (0.47–1.37) 
Dropped-out 273 104 0.56 (0.37–0.86) 1 0.98 (0.62–1.55) 
Waiting 162 75 0.43 (0.27–0.68) 1 n/a 
Injuries 
Operated 159 65 0.33 (0.20–0.57) 1 1.00 (0.59–1.70) 
Dropped-out 208 80 0.48 (0.32–0.73) 1 0.95 (0.59–1.53) 
Waiting 184 81 0.47 (0.31–0.71) 1 n/a 
Other presentation 
(not specified) 
Operated 131 67 0.30 (0.16–0.55) 1 1.33 (0.77–2.31) 
Dropped-out 174 69 0.78 (0.47–1.32) 1 1.61 (0.92–2.82) 
Waiting 164 58 0.42 (0.25–0.70) 1 n/a 
Digestive system 
illness 
Operated 138 63 0.39 (0.22–0.71) 1 2.02 (1.19–3.45) 
Dropped-out 168 85 0.57 (0.36–0.90) 1 1.03 (0.60–1.75) 
Waiting 116 61 0.25 (0.15–0.42) 1 n/a 
Neurological 
system illness 
Operated 114 51 0.33 (0.18–0.64) 1 0.62 (0.32–1.19) 
Dropped-out 167 62 0.63 (0.37–1.08) 1 1.31 (0.73–2.37) 
Waiting 103 55 0.32 (0.18–0.55) 1 n/a 
Respiratory 
system illness 
Operated 52 28 0.34 (0.14–0.83) 1 1.00 (0.43–2.32) 
Dropped-out 129 54 0.73 (0.40–1.32) 1 1.53 (0.79–2.97) 
Waiting 154 54 0.37 (0.22–0.65) 1 n/a 
System infection 
Operated 81 29 0.40 (0.16–0.99) 1 1.13 (0.47–2.71) 
Dropped-out 146 59 0.53 (0.28–1.01) 1 1.28 (0.63–2.59) 
Waiting 79 45 0.30 (0.15–0.61) 1 n/a 
Psychiatric illness 
Operated 31 16 0.68 (0.13–3.64) 1 4.85 (1.06–22.26) 
Dropped-out 97 27 0.70 (0.26–1.93) 1 0.84 (0.27–2.59) 
Waiting 42 16 1.19 (0.33–4.33) 1 n/a 
Urological system 
illness 
Operated 45 18 0.33 (0.08–1.27) 1 1.56 (0.49–4.92) 
Dropped-out 50 28 0.36 (0.14–0.93) 1 0.89 (0.33–2.37) 
Waiting 39 26 0.65 (0.27–1.55) 1 n/a 
Hepatobiliary 
system illness  
Operated 37 21 1.09 (0.33–3.56) 1 1.05 (0.25–4.24) 
Dropped-out 35 15 0.84 (0.25–2.84) 1 1.16 (0.27–4.92) 




Operated 19 14 0.54 (0.16–1.84) 1 0.91 (0.25–3.31) 
Dropped-out 48 33 1.26 (0.53–2.94) 1 1.50 (0.57–3.95) 
Waiting 37 24 0.25 (0.11–0.60) 1 n/a 
*Adjusted for age, sex and non-independent observation periods. Statistically significant differences are 
highlighted in bold 
 
Two studies with three months follow-up of all ED presentations post-RYGB or various 
procedures reported an increased number of conditions related to the surgery itself, e.g. 
postoperative complications [15, 17]. Supporting this notion, an increase in gastrointestinal 
presentations was also found in some other studies as a post-procedure complication, with 
abdominal pain being one of the most common reasons for ED presentation in the short-term 
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[12, 24]. Our study also revealed a significant increase in presentations for gastrointestinal 
illnesses within several years after bariatric surgery.  
Some studies have reported that patients present with mental health disorders more 
often after bariatric surgery than before [25, 26], and, in our study, a significant increase in 
presentations for psychiatric illnesses occurred in the publicly-operated group after the surgery. 
However, the absolute presentation rates were low, 1.3 per 100 person-years while waiting for 
surgery and 2.7 per 100 person-years post-operatively. Compared with the operated group, the 
dropped-out group tended to have higher presentation rates for psychiatric conditions both 
before and while waiting.  
Patients who had bariatric surgery were more likely to be admitted from the ED after 
surgery than before surgery. Their postoperative admission rate of 38.9% is similar to the 
admission rate of 34.9% in the study by Telem, although the latter study examined short-term 
presentations only after different types of bariatric procedures (LAGB, RYGB, sleeve 
gastrectomy) [18]. No studies known to us have compared the pre- and postoperative likelihood 
of admission. It is not clear whether the prevalence of conditions requiring admission during 
ED visits increased, whether medical practitioners were more inclined to admit postoperative 
patients, or whether this increase simply reflects an overall trend of greater severity of health 
conditions over time. 
Some economic evaluations show that costs eventually decrease a few years after 
surgery [2], although not immediately in the first years [5]. Further analysis is required to 
determine the economic effects for public hospitals. Our findings of non-decreasing rates of 
ED presentations and an increased likelihood of admission from the ED after bariatric surgery 
suggest that the policy of performing publicly funded bariatric surgery as LAGB did not reduce 
the burden on the public hospital system in Tasmania. However, further analysis is required to 
determine the economic impact for public hospitals as this study was looking at service use 
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rather than overall costs. Costs of ED presentations comprise only a fraction of total costs for 
the public system which include hospital admissions, inpatient time, outpatient costs and, 
particularly relevant to bariatric surgery, costs of revisional procedures [27, 28]. 
This study should not be interpreted as a comparison of operated-on patients with non-
operated-on patients, but rather as a comparison of patients who had publicly funded surgery 
with those who dropped-out from the public wait-list, even if they went on to have privately-
funded surgery, either self-funded or through private insurance. The study aimed to inform 
public payers of wait-list patient pathways and their impacts on hospital services use.  
Given that some reasons for hospital admissions and ED presentations changed 
significantly after bariatric surgery, costs are also expected to change and require evaluation. 
Moreover, there could be cost drift from individuals to public healthcare. It has been argued 
that increased hospital resource use and even increased costs should not limit access to public 
bariatric surgery due to the expected health benefits and mortality reductions [29]. 
This study included all patients wait-listed for primary public bariatric surgery in 
Tasmania and provided a long observation period of 13 years on average, which is greater than 
the observation periods reported in other studies of ED presentations. The postoperative 
observation period of three years is similar or greater than those in other studies [12, 15, 17, 
18]. Outcomes for the operated group were compared with those of a similar population of 
patients who were eligible for surgery in the public hospital system (as defined by placement 
on the wait-list). Few studies of healthcare resource utilisation have had comparison groups 
closely resembling the treatment group, if they have been available at all [10]. 
Our study did not provide comparisons between bariatric surgery types because all the 
procedures were LAGB. In a study of 36,673 patients that compared ED presentation rates not 
resulting in admissions within 90 days post-surgery, and that included different types of 
bariatric procedures, LAGB was associated with lower ED presentation rates than sleeve 
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gastrectomy or RYGB [15]. Similar results were shown in a study of ED presentations resulting 
in readmissions within 30 days for 130,007 patients [30]. In studies comparing sleeve 
gastrectomy and RYGB only, RYGB was associated with higher rates of ED presentations 
within one year in a study of 5,701 patients [31] and in a Saudi study of 301 patients operated 
within a five-year period without details of average follow-up time [32]. However, most of 
these studies were comparing short-term follow-up data only, representing immediate post-
surgical complications (and excluded for that reason from our study), and no conclusions on 
long-term emergency department presentations rates for different procedures could be drawn. 
This study has certain important limitations. It encompasses the population of only a 
single state, with a small number of bariatric surgeons operating publicly and laparoscopic 
adjustable gastric banding as the most commonly performed procedure (in contrast to current 
national and world trends [33]). While multidisciplinary management and long-term follow-up 
are associated with better LAGB results [34-36], and long-term complication rates are typically 
higher for patients lost for follow-up [37], our study was not able to account for patients’ 
adherence to postoperative follow-up. 
We also had to assume the type of publicly funded procedures outsourced to private 
hospitals, basing on routine surgeons’ practice. We relied on Tasmanian administrative 
databases, and thus, patients who left Tasmania or had emergency presentations while in other 
areas were not captured. Presentations to private hospital emergency departments could also 
not be tracked. Due to the inferior quality of the hospital medical records, we were not able to 
examine the relationships of ED presentations with weight and BMI; however, it is usual for 
administrative databases not to have anthropometric data, and for studies based on 
administrative data not to report on such associations [9, 18]. 
This study does not provide information on the impact of waiting time on public ED 
presentation rates. Future studies with a matched sample of individuals who are not wait-listed 
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for surgery would help to differentiate between aging and waiting time contributions to ED 
presentation rates. 
3.5 Conclusion 
We conclude that (i) the overall ED presentation rate did not decrease after publicly 
funded laparoscopic adjustable gastric banding; (ii) overall ED presentation rates were similar 
following publicly funded operations and drop-out from the wait-list; (iii) there were increases 
in specific ED presentation reasons after LAGB particularly for digestive system problems and 
psychiatric illnesses, with rates increasing for psychiatric illnesses after being placed on the 
wait-list; the absolute risk, however, remained low. and (iv) the likelihood of being admitted 
during an ED presentation increased after LAGB surgery. 
The results of the study suggest that publicly funded bariatric surgery performed as 
laparoscopic adjustable gastric banding does not reduce the burden on the public healthcare 
system in terms of emergency department service use over an average of three years. Further 
economic analysis is required to quantify the cost implications. 
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Chapter 4: Reoperations after secondary bariatric surgery: a systematic review 
Abstract 
This chapter reviews reoperation rates for short-and long-term complications following 
secondary bariatric procedures and need for further bariatric surgery. The search revealed 28 
papers (1317 secondary cases) following at least 75 % of patients for 12 months or more. For 
adjustable gastric banding (AGB), rebanding had higher re-revisional rates than conversions 
into other procedures. Conversion of AGB to Roux-en-Y gastric bypass had the highest number 
of short- (10.7%) and long-term (22.0%) complications. We estimated 194 additional 
reoperations per 1000 patients having a secondary procedure, 8.8 % needing tertiary surgery.  
Despite being poorly reported, risks of reoperations for long-term complications and 
tertiary bariatric surgery are higher than usually reported risks of short-term complications and 
should be taken into account when choosing a secondary bariatric procedure and for economic 
evaluations. 
  




Morbid obesity is a chronic condition with a significant burden on public healthcare. 
Bariatric surgery is currently the most effective way of treating morbid obesity and related 
diseases, particularly type 2 diabetes mellitus (T2DM) [1, 2]. As with any surgery, it does not 
have a 100% success rate, and complications, insufficient weight loss or poor comorbidity 
control may indicate the need for further bariatric operations. The reported incidence of 
bariatric surgery revisions has been as high as 50% in some series [3-5]. National registry data 
from Sweden, the UK and Russia indicate 3–8% of procedures are secondary bariatric 
operations, and as many as 17–20% in reports of other nations (United Arab Emirates, 
Netherlands) [6].  
In the past decade, there have been many publications on bariatric revisions, and 
revisional workshops and discussions attract considerable attention at bariatric conferences [7]. 
Surgeons have realised that the initial operation might be only the first step in the management 
of bariatric patients, but a Cochrane Collaboration review on bariatric surgery in adults 
revealed adverse event rates and reoperation rates are poorly reported [8].  
The true economic costs of bariatric surgery are therefore likely to be higher than have 
so far been reported, as most analyses to date have failed to account for the need for subsequent 
surgery, with a few exceptions [9, 10]. The only economic evaluation that does address this 
issue assigned the same probability for reoperation after all procedures [11]. 
While technical details of reoperations are described well and knowledge of the short-
term complications of revisional procedures is evolving rapidly, there is little information on 
what happens after revisional operations, what are the rates of long-term complications, and 
what is the rate of subsequent revisional bariatric surgery (re-revisions). Our systematic review 
aimed to describe patient pathways and the need for further surgery following a secondary 
bariatric procedure. 
Chapter 4: Reoperations after secondary bariatric surgery: a systematic review 
90 
 
4.2 Materials and methods 
In order to make results generally applicable, we looked only at conventional primary 
and secondary procedures such as adjustable gastric banding (AGB), Roux-en-Y gastric bypass 
(RYGB), sleeve gastrectomy (SG), biliopancreatic diversion (BPD) and BPD with duodenal 
switch (BPD-DS). Vertical banded gastroplasty (VBG) was also included because although it 
is almost abandoned, secondary operations are still performed in such patients. 
Terms for reoperative surgery are defined in Table 16. Our protocol to search PubMed 
and Cochrane databases used combinations of the terms “secondary”, “readmission” and 
“reoperation” combined with “bariatric”, “gastric banding”, “gastric bypass”, “sleeve 
gastrectomy”, “duodenal switch”, “biliopancreatic diversion” and “banded gastroplasty”, 
including their derivatives, in titles, abstracts, citations and terms. All identified review articles 
were also screened for references. The search was limited to ten years (2004–2014) to reflect 
changes in techniques and the widespread use of sleeve gastrectomy. Languages chosen for 
inclusion were English, Spanish, German, Russian, Ukrainian (papers in all those languages 
were used to identify pathways; however, only papers in English were finally included in the 
quantitative analysis). Only original studies of any design containing ten or more cases of 
revisions, reversals or conversions were eligible for inclusion. In order to make results of the 
review more generalisable, we excluded uncommon operative methods, with yet unestablished 
similarity of outcomes to conventional revisional, such as robotic surgery, single incision 
laparoscopic surgery, natural orifice transluminal endoscopic surgery and all endoscopic 
revisions. The range of primary procedures was limited to the conventional operations used as 
search terms. Based on the protocol definition of revisional, conversional and reversal 
procedures, we excluded operations that were performed after primary bariatric procedures for 
specific or non-specific complications and that did not change the anatomy created by the 
original procedure, i.e., hernia repairs, operations for internal hernias, surgical drains, and body 
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contouring procedures. Patient pathways were identified during the full-text analysis; we 
constructed flow-charts of the sequence of procedures that patients underwent and excluded 
studies if a definite sequence of procedures could not be identified for each patient. 
Table 16. Terms for reoperative bariatric surgery used in the review. 
Term Definition Examples 
Revision Operation that corrects or modifies anatomy of a 
bariatric procedure to improve the outcome in cases if 
this anatomy differs from originally intended or if it had 
not led to the planned outcome. This includes also 
device-related manipulations that do not lead to 
conversion or reversal as defined below. 
Resection of a dilated gastric 
pouch 
Re-sleeve gastrectomy 
Changing of limb length in Roux-
en-Y gastric bypass for 
insufficient weight loss 
Gastric band replacement for band 
slippage 
Conversion Changing anatomy of a bariatric procedure into anatomy 
of another distinct recognised bariatric procedure 
Roux-en-Y gastric bypass after 
LAGB 
Duodenal switch after sleeve 
gastrectomy 
Reversal Operation that restores original anatomy of GI tract Gastric band removal* 
















Revision of gastric banding with correction of band 




Revision of gastric banding using a new adjustable 
gastric band 
 
Rebanding Any of two previously mentioned revisional procedures 
involving replacement or repositioning of an adjustable 
gastric band 
 
*Staged procedures with reversal as the first step and intentions at that moment to perform the second step were 
considered as a single conversion procedure (e.g., planned two-stage conversion of adjustable gastric banding to 
sleeve gastrectomy). 
 
After identification of all possible pathways, papers were assessed to extract data on 
primary and secondary outcomes. The primary outcomes for this review were the rates of 
tertiary and subsequent bariatric procedures. Secondary outcomes were rates of complications, 
reoperations for reasons other than correction of a secondary bariatric procedure, and mortality. 
Complications were divided into short-term complications that occurred in the first 30 days 
after surgery and long-term complications occurring after more than 30 days. 
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Two reviewers assessed the quality of papers independently; papers that did not comply 
with the following criteria were excluded: 
1. Reporting all primary and secondary outcomes. 
2. Reporting both follow-up duration and proportion of followed patients after the 
secondary procedure. 
3. Average follow-up duration after the secondary procedure of at least 12 months. 
4. Follow-up reported for 75% or more of patients. 
5. Both primary and secondary outcomes had to be attributable to a clearly specified 
sequence of primary and secondary procedures. 
Patients were grouped according to the types of primary operations they had received, 
and subgroups were formed according to the secondary bariatric procedure. Relative risks (RR) 
were calculated for the pooled data, reported with 95% confidence intervals, χ2 tests and 
Fisher's exact tests were used to measure and compare differences between subgroups; p-values 
less than 0.05 were considered statistically significant. Statistical analysis was performed using 
Stata 12.1 software. 
4.3 Results 
After the initial search and removal of publications that duplicated study results, we 
identified 1591 papers, of which 106 contained traceable pathways for secondary bariatric 
procedures in 4734 patients.  
Of the identified papers, 28 had sufficient follow-up duration and proportions for 1317 
patients to be included in the quantitative analysis. The process of paper selection is depicted 
in Figure 14.  




Figure 14. Schematic diagram of the selection process for the studies included in the review. 
Detailed patient pathways based on the studies with sufficient follow-up are shown in 
Figure 15 (a–e by type of initial surgical procedure). Primary and secondary outcomes are 
summarised in Table 18. Table 19 reveals additional information on the reoperations for long-
term complications of secondary bariatric surgery. 
Reoperations after secondary bariatric surgery were common, with 194 re-reoperations 
for different causes per 1000 secondary procedures (regardless of the number of stages); with 
8.8% of patients receiving a tertiary bariatric procedure and 9.6% patients being reoperated for 
long-term complications of secondary bariatric procedures (these figures partially overlap). 
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This does not take into account body contouring operations that were not reported in any of the 
studies. 
Table 17. Studies selected for the quantitative analysis. 
LAGB – laparoscopic adjustable gastric banding, BPD – biliopancreatic diversion, RYGB – Roux-en-Y gastric 
bypass, SG – sleeve gastrectomy, VBG – vertical banded gastroplasty 
 
  



















1 Aarts [12] 2013 2000–2010 38 LAGB Band removal 36 100 





12, SG 2, RYGB 
2 
56 93 
3 Cordera [14] 2004 1986–2003 54 VBG RYGB 73 94 
4 Cusati [15] 2011 1990–2009 24 RYGB RYGB revision 14 100 
5 Dapri-1 [16] 2009 2002–2007 27 LAGB SG 18.6 85 
6 Dapri-2 [17] 2011 - 26 SG Re-SG 7, DS 19 24.4 92 
7 Dargent [18] 2009 1995–2008 98 VBG AGB 69 78 
8 Ee [19] 2013 1998–2009 163 LAGB Band 
replacement 
36 75 
9 Foletto [20] 2008 2000–2007 29 LAGB Band 
replacement 
26.9 100 
10 Gagne [21] 2011 1999–2010 105 VBG RYGB 26 100 
11 Gautier [22] 2013 2005–2010 18 SG RYGB 15.5 100 
12 Himpens [23] 2010 2002–2010 40 AGB SG 32.6 90 
13 Iannelli [24] 2013 2009–2011 20 RYGB RYGB revision 20 100 
14 Khan [25] 2013 - 20 LAGB SG 26 100 
15 Niville [26] 2005 1999–2001 10 LAGB Removal 48 100 
16 Perathoner 
[27] 
2013 2002–2012 108 AGB RYGB 41 89 
17 Poyck [28] 2012 2003–2008 35 AGB DS 36 83 
18 Rawlins [29] 2011 2002–2009 29 RYGB Distal RYGB 27 100 
19 Rebibo [30] 2012 2007–2011 15 SG Re-SG 12 100 
20 Schouten [31] 2006 1997–2005 29 AGB Band 
replacement 5, 
Band 
repositioning 19,  
BPD 3, RYGB 2 
34 100 
21 Schouten [32] 2007 -  101 VBG RYGB 38 100 
22 Silecchia [33] 2013 2008–2011 76 AGB SG 24 100 
23 te Riele [34] 2008 2002–2006 55 AGB RYGB 12.8 
(median) 
100 
24 Thill [35] 2009 2001–2008 40 VBG AGB 18 98 
25 Thoreson [36] 2008 1993–2008 27 VBG Reversal 32 96 




2006 1999–2004 47 AGB RYGB 12 87 
28 Wenger [39] 2005 - 13 VBG AGB 52 100 










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Chapter 4: Reoperations after secondary bariatric surgery: a systematic review 
97 
 
Figure 15. Details of bariatric reoperations in studies following patients for one year or 
more (AGB – adjustable gastric banding, BPD – biliopancreatic diversion, DS – duodenal 
switch, D-RYGB – distal Roux-en-Y gastric bypass, SG – sleeve gastrectomy, RYGB – Roux-
en-Y gastric bypass, VBG – vertical banded gastroplasty): 
a) Adjustable gastric banding revisions 
 
b) Adjustable gastric banding reversals and conversions 








d) Reoperations for sleeve gastrectomy  




e) Reoperations for Roux-en-Y gastric bypass 
Initially, the relative risk calculation was planned using a model weighting outcomes 
according to follow-up proportions and durations. However, on applying the model, it appeared 
that studies with lower follow-up proportions captured more events of interest, and assigning 
lower weights to those studies would result in a significant decrease in event proportions that 
would likely not truly reflect the underlying outcome rates. Therefore, unadjusted relative risks 
are presented.  
4.3.1 Bariatric reoperations after AGB 
Conversion of AGB into RYGB, as compared to other revision operations, had the 
highest complication rates (Table 18), both in the long and short term (p<0.001), with 10.7% 
short-term and 22.0% long-term complications. RYGB, when compared to rebanding, also had 
a trend towards a slightly higher long-term complication rate as a secondary procedure (RR 
1.4, 95% CI 0.9–2.1, p=0.09). It is possible that the difference in this outcome was influenced 
by different reasons for  the type of revision, however we could not establish a definite pattern 
for the revision choice in the studies included in the analysis. In the studies where LAGB was 
Chapter 4: Reoperations after secondary bariatric surgery: a systematic review 
100 
 
converted to different procedures the reasons for RYGB choice were opposite: insufficient 
weight loss [13] and initially good weight loss with gastric band intolerance [31], and other 
studies were addressing only a single type of revision for different reasons. The rate of 
complications requiring reoperations did not differ significantly between sub-groups of RYGB 
and rebanding (p=0.27). Sleeve gastrectomy after AGB had the lowest reported long-term 
complication rates (2.6%) and required the least number of reoperations for complications (RR 
0.2, 95% CI 0.1–0.4, p<0.001) compared to other types of secondary procedures, with only 
2.1% of reoperations for long-term complications. 
Performing any type of gastric banding as a revisional operation resulted in higher re-
revisional rates for any reason (complication or weight loss failure) than conversions into other 
procedures (RR 2.7, 95% CI 2.3–3.2, p < 0.0001), mostly due to reoperations for band-related 
complications (12.8%). 
Rates of tertiary reoperations for insufficient weight loss or weight regain were similar 
in patients who had band repositioning or replacement and those with sleeve gastrectomy after 
gastric banding (RR 1.1, 95% CI 0.8–1.6, p=0.53) and were performed in less than 7% of 
patients of those subgroups. In contrast, no tertiary operations were due to insufficient weight 
loss in patients converted from AGB to RYGB or BPD, which is statistically significant when 
compared to rebandings or conversions to SG (p=0.001). 
The total reoperation rate did not differ significantly between rebandings and 
conversions to RYGB after AGB, but the most common reason for operations for long-term 
complications after conversion to RYGB was incisional hernia repair (17 out of 25, or 68% of 
all reoperations performed for RYGB complications after 30 days). The only reported revision 
of RYGB after AGB was due to gastro-gastric fistula.  
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4.3.2 Bariatric reoperations after vertical banded gastroplasty 
Results of VBG conversion to AGB or RYGB were different; although the rate of 
tertiary operations was higher after AGB, with 10.6% of conversions to AGB being revised vs 
4.6% of conversions to RYGB (RR 1.6, 95% CI 1.1–2.3, p=0.03), the rate of complications 
requiring reoperations was significantly lower, with 10.6% conversions to AGB being 
reoperated for complications compared to 22.3% conversions to RYGB (RR 0.5, 95% CI 0.3–
0.8, p<0.01). This resulted in a higher average number of operations per person when VBG 
was converted to RYGB rather than to AGB (p=0.03). 
4.3.3 Bariatric reoperations after sleeve gastrectomy 
Re-SG and conversions to RYGB or BPD-DS were included in this group. However, 
the number of patients with long-term follow-up after reoperations for sleeve gastrectomy was 
small, and there were no differences in complication (p=0.12) and reoperation (p=0.21) rates 
between subgroups. However, all (15.8%) long-term reoperations were in the BPD-DS 
subgroup. 
4.3.4 Bariatric reoperations after Roux-en-Y gastric bypass 
No reversals or conversions of RYGB were included in the analysis, although there 
were reports in the excluded studies. Revisions of RYGB were divided into two subgroups 
depending on the area and type of revision. Results of pouch reduction or 
gastrojejunoanastomosis revision were compared with lengthening of biliopancreatic limb. 
Despite no difference in the rate of tertiary operations (p=0.4), distal RYGB resulted in higher 
complication rates and more reoperations for complications (RR 2.6, 95% CI 1.7–4.0, p<0.01). 
In total, lengthening of the biliopancreatic limb resulted in short-term complications in 48% of 
patients (surgical site infections and deep vein thrombosis), and 55% experienced long-term 
complications (abdominal wall hernias, malnutrition, small bowel obstruction). However, the 
comparison included only a single cohort in each subgroup. 




There is a big gap in the literature on medium- to long-term outcomes of revisional 
bariatric surgery. This review is the first summary of patient surgical pathways after secondary 
bariatric surgery with the aim of improving our understanding of the reoperations and 
complications rates after secondary bariatric surgery. It was challenging to address this in a 
systematic way for a number of reasons. While the current literature contains information on 
patient pathways following secondary bariatric surgery, papers do not typically report 
reoperations and long-term complications in a structured way, so sequences of complications 
and reoperations could be reconstructed only after a thorough full-text analysis. Moreover, 
difficulties in tracking reoperations arise because of a lack of centralised databases for bariatric 
surgery outcomes that would allow follow-up of patients who migrate between bariatric 
centres. Some of the studies, especially in large centres, reported performing secondary or even 
tertiary operations for patients coming from other clinics. Overall, the actual numbers of 
published cases of tertiary and subsequent operations remain very low compared to the amount 
of publications on short-term outcomes of revisional bariatric surgery, possibly due to 
publication bias.  
Surprisingly, the number of published studies looking at the long-term results of sleeve 
gastrectomy revisions is very low, despite enormous numbers of the procedure performed. 
Those studies with longer follow-up duration did not follow-up sufficient proportions of 
patients, nor did they report outcomes in a structured way to allow non-ambiguous data 
extraction, resulting in only 59 patients being included in this review. The same was true for 
mini-gastric bypass, with only one study meeting our criteria identified, and this failed to 
differentiate reoperations after conversions to RYGB and SG. 
Despite these challenges, the findings suggest that reoperations after secondary 
bariatric surgery are common, but their rates and, more often, reasons vary by type of primary 
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and secondary procedure. Particular issues arise with AGB; high re-revision and weight loss 
failure rates after gastric rebanding suggest that retaining the gastric band at the time of a 
secondary procedure may not be the optimal choice. For example, a prospective study of 
secondary AGB and RYGB by Muller found 45% of failures after rebanding compared to 20% 
after conversion to RYGB [40]. Another interpretation of inferior rebanding results is that the 
reason for failure of the primary AGB may well be inadequate follow-up [41]. If a rebanding 
is followed by further poor follow-up, repeated poor results would not be surprising. Eating 
training and band follow-up with experienced adjusting have been shown to be important for 
optimal results from AGB. Management with AGB should be envisioned as the AGB surgery 
plus ongoing experienced support. 
Conversions of all types of primary procedures (except SG) into RYGB or BPD-DS 
appear to carry an increased risk of incisional hernia, likely due to an increased number of 
laparotomies or conversion to laparotomies, but those rates could not be ascertained from most 
of the studies. Another common complication was malnutrition after conversion to BPD-DS or 
distal-RYGB, although it was usually managed without further reoperations. 
In contrast, in reoperations for VBG, AGB may be a better option than RYGB because 
despite significant increases in the need for tertiary operations after band placement, the clinical 
significance of more complications and reoperations for complications after conversion to 
RYGB may prevail. However, there are no studies comparing long-term outcomes of different 
secondary strategies to provide more conclusive recommendations. 
Another notable finding of this review is the high rate of bariatric procedures after 
bariatric reversals (up to 45% after AGB removal) [12, 42, 43]. Very few studies have looked 
at what happened to patients after their procedure was reversed, so the actual number of patients 
who return to bariatric surgeons after re-evaluating their decision might be even higher. 
Overall, the long-term outcomes of band removals are uncertain because patients are often lost 
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to follow-up and tend to re-appear in reports only after they decide to have another bariatric 
procedure. In addition, reversals of other (non-AGB) operations can result in further bariatric 
procedures [44]. Therefore, as stated by Buchwald, a reversal of a bariatric operation should 
not mean the end of the professional obligation for ongoing care [7], as future operations may 
still be required. 
Quantitative weight loss outcomes after reoperations were not evaluated in this review 
due to the heterogeneity of the studies included but this is still an important question and should 
be investigated in a more specific study. Quality of life after revisional bariatric surgery is also 
an under-investigated topic. Patient stories cannot be fully represented in statistics of failures 
and reoperations, and sequential procedures are burdensome for patients. Wenger tells of a 
patient who developed band intolerance after VBG followed by AGB but declined further 
operations and lived on liquids only [39]. This implies that long-term studies of sufficient 
length are required to investigate the impact of subsequent surgery on health-related quality of 
life. 
Additional costs associated with long-term complications, reoperation probabilities and 
weight loss failure after secondary bariatric operations should also be addressed in economic 
models evaluating bariatric surgery, which generally fail to account for them. 
Long-term nationwide follow-up of all bariatric patients, regardless of their current 
procedure status, is needed to fully assess the outcomes of bariatric surgery. There are methods 
to achieve this in large population groups, including through bariatric registries in the UK, 
Sweden and Russia [6] that distinguish between primary and secondary operations and follow 
their outcomes. Existing bariatric registries could provide a snapshot of trends and long-term 
outcomes of secondary bariatric procedures on a countrywide scale, though published reports 
have not specifically described this subgroup of procedures. There is no summary of outcomes 
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in low- and high-volume centres and whether results of centres specialising in secondary 
treatments are different from standard high-volume centres. 
There are several limitations of this review. The main limitation comes from the scope 
of the included studies, which were mostly case series of a single revision type without a 
comparison group and with insufficient follow-up to establish long-term outcomes of different 
secondary procedures. In addition, our focus was not on the primary outcomes of the reviewed 
studies (excessive weight loss mainly) but rather on the extracted co-reported data, which could 
be incomplete. The analysis of case-series rather than comparative studies made it impossible 
to evaluate publication bias using standard methods.  
In summary, this review has revealed the gaps in the literature that limit our 
understanding of patient outcomes after secondary bariatric operations and the medical 
attention this population needs. In fact, the whole discussion section may seem to be focused 
on limitations of implications of the results of the study; however, this is the main finding, that 
current literature does not properly address this large and complex group of patients. 
Overall, based on the findings of this review, we recommend the following: (i) more 
thorough data capture of bariatric reoperations and their outcomes, including in bariatric 
registries; (ii) continued evaluation of outcomes for patients after bariatric reversals; (iii) well-
designed comparative studies to determine optimal secondary procedures after specific primary 
operations; (iv) accounting for the need for additional operations after secondary bariatric 
surgery in economic evaluations; and (v) studies of quality of life after secondary bariatric 
surgery using validated generic and disease-specific instruments. 
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Abstract 
Background: Most bariatric surgery procedures in Australia are performed in the 
private sector but many eligible patients are uninsured. This creates significant pressure on the 
public system. Australia-wide, public hospitals perform a higher proportion of revisional 
procedures than private hospitals (36% vs 25%), possibly limiting access to primary 
procedures. This study investigated proportions of publicly funded bariatric surgery that were 
primary and revisional and explored waiting times and public hospital service use by patients 
wait-listed for revisional surgery compared with those who only had primary bariatric surgery 
in Tasmania, Australia. 
Methods: Data on all patients wait-listed for public bariatric surgery in 2008–2013 and 
their public hospital admissions and ED presentations during 2006–2014 were extracted from 
administrative databases and digital medical records. Hospital admission and emergency 
department (ED) presentation rates and days in hospital per year were compared between those 
who received primary bariatric surgery only and patients ever wait-listed for revisional surgery 
using incidence rate ratios of these variables between primary-only and revisional surgery 
recipients and between periods on the wait-list and after surgery. IRRs were derived using a 
negative binomial regression mixed-effects model adjusting for age, sex and non-independent 
observation periods. 
Results: In total, 273 patients had publicly funded surgery with laparoscopically 
adjustable gastric bands (LAGB) or were wait-listed for LAGB revisions. 178 (27.3%) of 652 
patients wait-listed for primary bariatric surgery and 90 (94.7%) of 95 patients wait-listed for 
LAGB revisions had their operations as planned. Out of a total of 320 bariatric surgery 
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procedures, 142 (44.8%) were performed for revisional surgery including unplanned and 
second or subsequent revisions. The mean wait-list time for primary surgery was significantly 
longer than for any subsequent revisional surgery: 4.1±2.8 vs 0.8±1.0 years. Compared with 
primary-only surgery recipients, revisional surgery recipients had higher public hospital 
admission rates (IRR 2.60, 95% CI 1.63–4.13 while on wait-list and IRR 1.98, 95% CI 1.31–
2.98 post-surgery); more days in hospital per year (IRR 2.68, 95% CI 1.44–4.99 while on wait-
list and IRR 2.10, 95% CI 1.18–3.76 post-surgery); and higher ED presentation rates after the 
surgery (IRR 1.76, 95% CI 1.15–2.70).  
Conclusion: Revisions constituted a substantial proportion of publicly funded bariatric 
surgery in Tasmania. Patients requiring revisional surgery used more hospital services than 
primary surgery recipients before and after their respective surgery. Bariatric surgery planning 
in the public sector should make adequate provision for revisional surgery patients to account 
for their more frequent and prolonged hospital in-patient stays and increased rates of ED 
presentations. 
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5.1 Introduction 
Bariatric surgery is currently the most effective treatment for morbid obesity and related 
comorbidities [1] and is recommended in guidelines for publicly funded practice in some 
countries [2-4]. According to the International Federation for the Surgery of Obesity and 
Metabolic Disorders (IFSO) Global Registry, 52.1% of operations were funded by public 
health services with wide variation (0–100%) among countries [5, 6]. The demand for bariatric 
surgery is substantial, and in publicly funded systems such as in the UK or Canada, only a 
small minority of patients eligible for bariatric surgery receive it [7, 8]. The majority of bariatric 
procedures (88%) in Australia are performed in the private sector [9], but many patients eligible 
for surgery experience socioeconomic disadvantage or have no private insurance (46%), which 
creates increasing pressure on the public system [10]. The need to prioritise patients who will 
benefit the most and calls for the expansion of public service provision have emerged. 
Nevertheless, a recent review suggests that in many countries, the only criterion for prioritising 
bariatric surgery patients in the publicly funded health system is waiting time [11], whereas 
from some patients’ and clinicians’ perspectives, other prioritisation criteria based on the 
clinical staging of obesity are considered more appropriate [12]. 
Reoperations after bariatric surgery are common. Commonly named revisional bariatric 
surgery or revisions, these operations include correction or modification of bariatric 
procedures, conversions into a different type of procedure or restoration of the original anatomy 
(reversal) [13]. National registries and individual country reports demonstrate rates of 
revisional surgery of 3–8 % in the UK, Sweden, Russia and France [5, 14], with certain 
countries such as Belgium, France, the Netherlands performing even more revisional surgeries 
[15]. According to the Australian Institute of Health and Welfare (AIHW) data for 2014–2015, 
37% of bariatric procedures performed in Australian public hospitals were revisional. 
However, the AIHW does not provide data on the proportions of surgery that are revisional in 
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Tasmania, Northern Territory and Australian Capital Territory [16]. The BSR report, while not 
capturing all Australian data, showed that in 2016–2017 in the participating private hospitals, 
25% of bariatric procedures were revisional, whereas 36% of procedures were revisional in the 
public system [9]. As more primary surgeries are performed, the demand for revisional bariatric 
surgery is also expected to increase, as evidenced in the Australian public system, where in 
2005 only 20% of procedures were revisional [16]. However, existing guidelines and 
recommendations have not considered revisional surgery as a separate entity when determining 
indications for surgery and patient prioritisation [4]. 
Revisional bariatric surgery, in comparison with primary surgery, is also associated 
with significantly higher complication and adverse event rates [17], as shown in an Australian 
report in which 7.3% of revisional procedures had a complication (unplanned return to theatre, 
admission to intensive care unit or re-admission to hospital) compared with 2.4% of primary 
procedures [9]. Therefore, the increasing numbers of revisional procedures are likely to create 
an additional burden on the public health system in the postoperative period that should be 
taken into account by service planners. 
We have previously shown long waiting times for patients wait-listed for primary 
public bariatric surgery in Tasmania (Chapter 2). We hypothesised that patients placed on the 
wait-list for revisional bariatric surgery would have shorter wait-list times and higher public 
hospital service use than primary bariatric surgery recipients. This retrospective statewide 
cohort study aimed to assess the demand for revisional bariatric surgery in the public sector, 
and to evaluate the accessibility of publicly funded bariatric surgery and the use of public 
hospital services by patients wait-listed for revisional compared with primary bariatric surgery. 
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5.2 Materials and methods 
This retrospective statewide cohort study included all public hospital admissions and 
emergency department presentations in 2006–2014 for patients who had primary or revisional 
surgery following placement on the wait-list for public bariatric surgery in Tasmania in 2008–
2013. There are three main public hospitals in Tasmania and several small inpatient facilities. 
Bariatric surgery in Tasmania is performed in the public and private systems: public surgery is 
performed in two public hospitals, with some procedures outsourced to private hospitals but 
funded publicly. 
All patients placed on the wait-list for public bariatric surgery in Tasmania in 2008–
2013 were identified using three administrative databases (multiple databases contain this 
information due to system migration over time and structural changes in the state Department 
of Health). The wait-list data contained dates of wait-list placements and removals as well as 
removal reasons (e.g., procedure completed, patient lost to follow-up or procedure not 
required). 
Additional extraction of data from hospital medical records was performed to identify 
placements for revisional bariatric surgery (if they had notes for previous bariatric surgery or 
procedure details suggesting a revision of a previous bariatric procedure). Detailed recording 
of anthropometric data was poor for most patients in the hospital records and therefore did not 
allow us to perform an analysis of patients’ weights and BMIs. 
All public hospital admissions in all public inpatient facilities and all emergency 
department presentations to all three public hospitals in the period 2006–2014 were extracted 
from the administrative databases. Data on admissions and emergency presentations included 
dates and reasons for service utilisation (ICD-10 codes, diagnosis-related groups and urgency-
related groups).  
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To compare primary bariatric surgery recipients who did not require further revision 
with those who required revisional surgery, patients were divided into two groups: 1) patients 
who received primary bariatric surgery only and were never considered for revisional bariatric 
surgery in the sampling period of 2008–2013, or to the end of follow-up after surgery to the 
end of 2014; and 2) those who were ever wait-listed for revisional bariatric surgery during the 
2008–2013 sampling period. Patients who were wait-listed for primary bariatric surgery and 
were still on the wait-list (n=238) or were removed from the wait-list without receiving primary 
bariatric surgery (n=236) were excluded from the analysis. 
We examined the waiting times for primary and revisional surgery, the proportion of 
bariatric surgery procedures in the public system that were revisional, and the proportion of 
patients undergoing revisional surgery in the public system whose primary bariatric surgery 
was not included in public system records after 2006 – these patients were assumed to have 
undergone their primary bariatric surgery privately, though this could not be ascertained. All 
public hospital admissions and emergency department presentations were assigned to a period 
in relation to the wait-list time. For the recipients of only primary bariatric surgery, these 
periods were (a) while waiting and (b) after the primary procedure. For the patients ever wait-
listed for revisional surgery, the periods were (a) while waiting for revisional surgery and (b) 
after removal from the wait-list, whether for revisional surgery or drop-out. If a patient had 
more than one revisional surgery wait-list placement, then only the first placement was used to 
define these periods. Additionally, to ensure the validity of the observation periods, patients 
were linked to the Tasmanian death registry and the observation periods were adjusted to the 
dates of death for patients who died before the end of 2014. 
Admission records with interfacility transfer were treated as single admission. When 
calculating admission rates and days of hospital stay per year, admissions for planned wait-
listed bariatric procedures were excluded, as well as admissions for bariatric procedures that 
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were subsequently cancelled or postponed. ED presentation rates were calculated excluding 
ED presentations within 30 days post-surgery (as an increase in presentations was expected in 
this period). Total admission and emergency department presentation rates included person-
time for people without any admissions or ED presentations during the study period. Person-
time for admissions was reduced by the length of hospital stay in each period because patients 
were not at risk for another admission while admitted. They were still at risk for ED 
presentations though, such as during interfacility transfer.  
A negative binomial mixed-effects regression model was used to derive incidence rate 
ratios (IRR) with 95% confidence intervals (CI) for hospital admissions, days in hospital per 
year and ED presentation rates between observation periods and groups, including interaction 
between these two variables. Mixed-effects regression with a random intercept for participant 
was used due to non-independent observation periods for individual participants. IRRs were 
estimated for time at risk in each period, and the model was adjusted for sex and age at the start 
of each period.  
Differences between patients’ characteristics were compared using χ2– and t-tests, and 
p-values less than 0.05 were considered significant. Statistical analysis was performed using 
Stata 14.2 software. 
5.3 Results 
5.3.1 Bariatric surgery pathways and outcomes 
We identified 652 patients who were wait-listed for primary bariatric surgery, of whom 
178 (27.3%) had a primary procedure in the study period. Of the 178 patients, 109 had primary 
bariatric surgery (laparoscopic adjustable gastric banding – LAGB) in public hospitals. The 
remaining 69 patients had publicly funded bariatric surgery outsourced to private hospitals and 
no additional records on procedure details were available. However, it was ascertained by the 
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only surgeon performing outsourced publicly funded bariatric operations, that all the 
procedures were LAGB. Of the 178 patients who received primary bariatric surgery after being 
on the wait-list in the sampling period, 9 (5.1%) were later wait-listed for a secondary bariatric 
procedure and were included in the revisional group for the hospital service use analysis. 
Additionally, through hospital admission details, we identified 4 more patients who had non-
wait-listed revisional surgery. A further 95 patients were identified who were wait-listed in the 
same period initially for revisional bariatric surgery. A total of 64 (67.4%) had no previous 
records of bariatric surgery in the public system and were assumed to have had primary surgery 
in the public system prior to the study period or to have been transferred from the private system. 
Of the 95 patients initially wait-listed for revisional surgery, 90 (94.7%) received the 
surgery for which they were listed, compared with 178 (27.3%) out of 652 patients wait-listed 
for primary surgery in the same period. Only four (4.2%) patients awaiting a revision dropped-
out from the wait-list, though two of these patients later had a non-planned revisional surgery. 
Patients’ pathways following wait-list placements and surgical procedures are depicted in 
Figure 16 and Figure 17. 
In total, there were 138 wait-list placements for revisional surgery (including second 
and subsequent revisions), of which 130 (94.2%) placements resulted in revisional surgery. 
The average waiting time for the primary procedure was 4.1±2.8 years, with a maximum 
waiting time of 11.3 years, whereas the average waiting time was 0.8±0.9 years, with a 
maximum waiting time of 6.7 years, for the first revisional procedure (p < 0.0001) and 0.8±1.0 
years across all revisional procedures including subsequent revisions.  
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Figure 16. Flowchart summarising patient pathways (compared groups highlighted: primary 
surgery only – green, wait-listed for revisional surgery – red) 
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Including 12 non-planned revisions (i.e., revisions that were performed without the 
patient first appearing on a wait-list), 142 (44.8%) revisional procedures were performed out 
of 320 procedures with public funding. When counting only the procedures performed in public 
hospitals, without the outsourced surgeries, 140 (56.2%) of 249 were performed for revisional 
surgery. When 62 minor revisions (LAGB-port revisions) were excluded, revisional surgery 
still constituted 78 (41.7%) of 187 bariatric procedures in Tasmanian public hospitals, or 80 of 
258 (31.0%) publicly funded procedures. 
5.3.2 Public hospital service use 
We identified 1351 public hospital admissions and 2448 ED presentations for 165 
patients who had only primary bariatric surgery (primary group), and 104 patients who had 
ever been wait-listed for revisional surgery (revisional group). Four patients who had a non-
wait-listed (urgent) revisional surgery after a primary procedure were excluded from this 
analysis as they did not satisfy the definition of either group and did not have a revisional 
waiting period. The patients’ characteristics are described in Table 20. There were no 
significant differences between the groups in age, sex or total observation time. The wait-list 
observation time was shorter for the secondary group due to shorter wait-list times.  











Age at time of first recorded wait-list placement, years (SD) 42.8 (11.3) 44.1 (10.2) 
Males, % (n) 25.5 (42) 16.4 (17) 
Aboriginal or Torres Strait Islander origin, % (n) 4.9 (8) 6.7 (7) 
Observation time during wait-list period, years (SD) 3.6 (2.1) 0.8 (1.1) 
Observation time after removal from wait-list, years (SD) 3.1 (1.6) 3.2 (1.7) 
*Statistically significant differences are highlighted in bold. 
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The primary-only group had 40.3 admissions per 100 person-years while waiting for 
surgery, and 50.5 admissions per 100 person-years after the operation. The revisional group 
had a higher rate of hospital admissions both while waiting for revisional surgery (89.5 
admissions per 100 person-years, IRR 2.60, 95% CI 1.63–4.13) and after the revisional surgery 
(97.4 admissions per 100 person-years, IRR 1.98, 95% CI 1.31–2.98). When comparing 
observation periods within groups, there was no significant change in admission rates after the 
surgery in either group (Table 21 and Table 22). 





On wait-list Post wait-list Total 
Primary-only 497 40.3 50.5 44.9 
Revisional 399 89.5 97.4 95.7 
     
Total 896 46.9 68.8 58.8 
 




On wait-list Post wait-list 
 IRR between groups 
Primary-only 1 1 
Revisional 2.60 (1.63–4.13) 1.98 (1.31–2.98) 
 IRR between periods 
Primary-only 1 0.98 (0.73–1.31) 
Revisional 1 0.75 (0.51–1.09) 
*Adjusted for age, sex and non-independent observation periods. Statistically significant differences are 
highlighted in bold. 
 
Similar trends were observed when analysing days of stay in hospital per year. Patients 
in the primary-only group had a rate of in-hospital stay of 1.0 day per person-year while waiting 
(0–68.8 days per year), and 2.5 days per person-year after the surgery (0–95.6 days per year). 
The revisional group had higher rates of in-hospital days per year both while on the wait-list 
for a revision (4.3 days per person-year, 0–62.8 days per year, 95% CI 1.44–4.99) and after the 
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revisional surgery (3.7 days per person-year, IRR 2.10, 0–84.0 days per year, 95% CI 1.18–
3.76). There were no significant changes between periods within groups (Table 23 and Table 
24). 
Table 23. Days in public hospital per person-year (unadjusted)  
Revisional status Days in 
hospital 
Study period 
On wait-list Post wait-list Total 
Primary-only 1887 1.0 2.5 1.7 
Revisional 1615 4.3 3.7 3.8 
     
Total 3502 1.4 3.0 2.3 
 
Table 24. Adjusted* days in public hospital per year incidence rate ratios (IRR) with 95% 
confidence intervals 
Revisional status Study period 
On wait-list Post wait-list 
 IRR between groups 
Primary-only 1 1 
Revisional 2.68 (1.44–4.99) 2.10 (1.18–3.76) 
 IRR between periods 
Primary-only 1 1.21 (0.80–1.82) 
Revisional 1 0.94 (0.57–1.55) 
*Adjusted for age, sex and non-independent observation periods. Statistically significant differences are 
highlighted in bold. 
 
There was no difference in the ED presentation rates between primary-only and 
revisional patients while waiting for surgery (IRR 1.28, 95% CI 0.77–2.13). However, after the 
surgery, patients who did not require revisional operations (primary-only group) had lower 
presentation rates than those who underwent revision (IRR 1.76, 95% CI 1.15–2.70) (Table 25 
and Table 26). 
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Table 25. Public hospital ED presentation rates per 100 person-years (unadjusted)  
Revisional status 
Number of ED presentations Study period 
On wait-list Post wait-list Total 
Primary-only 750 66.2 64.6 65.5 
Revisional 400 73.4 101.6 95.6 
     
Total 1150 67.1 79.1 73.6 
 




On wait-list Post wait-list 
 IRR between groups 
Primary-only 1 1 
Revisional 1.28 (0.77–2.13) 1.76 (1.15–2.70) 
 IRR between periods 
Primary-only 1 0.97 (0.73–1.29) 
Revisional 1 1.34 (0.88–2.02) 
*Adjusted for age, sex and non-independent observation periods. Statistically significant differences are 
highlighted in bold. 
 
5.3.3 Reasons for public hospital admissions and ED presentations 
The most common reasons for hospital admissions and ED presentations were 
identified using major diagnostic categories (Table 27) and urgency related groups major 
diagnostic blocks (Table 28) respectively. The study did not have enough power to evaluate 
incidence rate ratios for specific reasons of public hospital admissions and ED presentations 
between groups and periods using the model adjusted for sex, age and non-independent periods, 
but the following trends were observed. In the revisional group after the surgery, there was an 
increase in admission rates for mental disorders (from 5.9 to 25.3 admissions per 100 person-
years) and for digestive system disorders (from 6.9 to 12.7 admissions per 100 person-years). 
The revisional group had also disproportionally high admission rates in all periods compared 
with the primary surgery only recipients for mental disorders (20.8 vs 2.9 admissions per 100 
person-years), diseases of the nervous system (16.1 vs 3.8 admissions per 100 person-years) 
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and injuries and intoxications (15.9 vs 1.5 admissions per 100 person-years). We did not 
observe differences of similar magnitude in the ED presentations. 
Table 27. Admission rates (unadjusted) per 100 person-years for the most common (≥50 
admissions) major diagnostic categories (MDC). 
MDC Wait-list status Absolute numbers for the 
total period 
Admission rates per 100 py in 
periods 






Primary-only 32 6 3.2 2.6 2.9 
Revisional 92 9 5.9 25.3 20.8 
Total 124 15 3.6 11.7 8.0 
D&D of the nervous 
system 
Primary-only 42 24 4.0 3.6 3.8 
Revisional 71 8 15.7 16.2 16.1 
Total 113 32 5.7 8.6 7.3 
D&D of the digestive 
system 
Primary-only 46 27 4.0 4.4 4.2 
Revisional 50 30 6.9 12.7 11.3 
Total 96 57 4.4 7.7 6.2 
D&D of the circulatory 
system 
Primary-only 76 30 6.5 7.3 6.9 
Revisional 16 10 3.9 3.5 3.6 
Total 92 40 6.1 5.8 5.9 
Injuries, poisoning and 
toxic effects of drugs  
Primary-only 17 16 0.7 2.6 1.5 
Revisional 70 41 21.6 14.1 15.9 
Total 87 57 3.7 7.2 5.6 
D&D of the 
musculoskeletal system 
and connective tissue 
Primary-only 50 31 3.7 5.5 4.5 
Revisional 27 13 13.8 3.8 6.1 
Total 77 44 5.1 4.9 5.0 
D&D of the skin, 
subcutaneous tissue and 
breast 
Primary-only 60 21 4.2 6.9 5.4 
Revisional 13 10 2.0 3.2 2.9 
Total 73 31 3.8 5.4 4.7 
Factors influencing health 
status and other contacts 
with health services 
Primary-only 20 19 0.5 3.4 1.8 
Revisional 38 14 5.9 9.4 8.6 
Total 58 33 1.3 5.8 3.7 
* D&D - diseases and disorders  
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Table 28. Emergency department presentation rates (unadjusted) per 100 person-years for the 
most common (≥40 presentations) urgency related group major diagnostic blocks (URG 
MDB)  
 
URG MDB Wait-list status Absolute numbers for the 
total period 
ED presentation rates per 100 py in 
periods 




Primary-only 24 10 1.6 2.7 2.1 
Revisional 17 6 4.4 4.0 4.1 
Total 41 16 1.9 3.2 2.6 
Injury (multiple sites, 
single site major and 
minor) 
Primary-only 114 48 12.0 7.5 10.0 
Revisional 59 18 7.8 15.8 14.1 
Total 173 66 11.4 10.7 11.1 
Circulatory system 
illness 
Primary-only 116 40 9.4 11.0 10.1 
Revisional 46 24 7.8 11.9 11.0 
Total 162 64 9.2 11.3 10.4 
Digestive system 
illness 
Primary-only 95 45 6.8 10.2 8.3 
Revisional 52 30 13.3 12.2 12.4 
Total 147 75 7.6 11.0 9.4 
Neurological system 
illness 
Primary-only 79 35 9.6 3.5 6.9 
Revisional 29 16 7.8 6.7 6.9 
Total 108 51 9.4 4.8 6.9 
System infection 
Primary-only 58 18 4.4 5.9 5.1 
Revisional 16 9 2.2 4.3 3.8 
Total 74 27 4.1 5.3 4.7 
Respiratory system 
illness 
Primary-only 34 20 3.0 2.9 3.0 
Revisional 12 8 1.1 3.3 2.9 
Total 46 28 2.8 3.1 2.9 
Psychiatric illness 
Primary-only 24 10 1.6 2.7 2.1 
Revisional 17 6 4.4 4.0 4.1 
Total 41 16 1.9 3.2 2.6 
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5.4 Discussion 
In this statewide population-based study, we were able to identify all patients wait-
listed for public primary or revisional bariatric procedures during a 6-year period. For these 
patients, we identified all public hospital admissions and emergency department presentations 
along with non-planned revisional bariatric procedures with more than three years of 
postoperative follow-up, which represents significant increases in both time and follow-up 
proportions compared to most reported studies [13]. This study is also the first to focus 
specifically on public revisional bariatric surgery, which was previously mentioned only in 
registries and reports. 
We demonstrated that revisional bariatric surgery constituted a large proportion of 
public bariatric surgery in Tasmania with the majority of revisional patients likely coming to 
the public sector after a primary procedure in private hospitals, and revisional bariatric surgery 
was associated with significantly shorter wait-list times compared with the wait-list times for 
patients waiting for a primary bariatric procedure. These findings are consistent with those 
from a recent study from South Australia, which also revealed that at least 51% of revisions in 
public hospitals followed previous bariatric surgery that occurred in the private sector, and with 
significant impact on the wait-list time for public surgery [18]. In our study, patients receiving 
revisional bariatric surgery also tended to come to the public sector from both public and 
privately funded primary bariatric surgery. This private-to-public patient transfer may occur 
due to the inability of patients to maintain private insurance for a prolonged time with some 
patients in our experience dropping their insurance shortly after obtaining their primary 
bariatric procedure. This can also occur when patients self-fund their primary procedure in a 
private hospital, and then cannot afford, or do not wish to have, revisional procedures in the 
private setting. With increasing numbers of patients having bariatric surgery, public resources 
may be tied up by revisional surgery, restricting access to primary surgery. Revisional surgery 
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is an important part of managing these patients and must be reflected in policies and planning, 
especially when revisional surgery has higher priority rates as reflected by shorter average 
waiting times. 
Our previous studies have shown that hospital service use does not decrease in the first 
years postoperatively after primary bariatric surgery (Chapter 2 and Chapter 3). In this study, 
we performed further sub-group analysis that showed that hospital service use did not change 
significantly for patients who have primary LAGB only. Adding revisional surgery patients to 
the analysis showed that patients requiring revisional surgery use more public hospital services 
than the recipients of primary surgery only, even when the hospital service use for the surgery 
itself is excluded from the analysis.  
This study has some limitations. We were limited to public healthcare data and were 
not able to identify details of primary operations that occurred in the private system or primary 
surgery in the public system prior to 2006. We therefore had to assume that in some instances 
revisional surgery was for patients whose primary operation was in the private system, which 
was consistent with clinical experience.  
The study focused on a cohort and time when laparoscopic adjustable gastric banding 
was the predominant procedure in Tasmania, but the findings, although not directly applicable 
to settings where other procedures are performed, still provide important information on the 
application of gastric bands in the public system. 
The study results have implications for further planning of bariatric surgery in the 
public sector. Public health care should be ready to deal with an increasing burden of revisional 
surgery for patients coming from both the public and private sectors. Public health care should 
plan for not only the provision of surgery but also increased numbers of hospital admissions 
and ED presentations in the short- and medium-term, especially for patients requiring 
revisional surgery. 
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In addition to implications for decision-makers in the public system, our findings have 
implications for patients undergoing bariatric surgery in the private sector, who should be 
informed of the likelihood of further revisions, hospital admissions and emergency 
presentations and therefore advised to maintain their insurance if possible and ensure that their 
insurance policies cover the possible longer-term complications of bariatric surgery. 
5.5 Conclusion 
We conclude that (i) revisions constituted a substantial proportion of publicly funded 
bariatric surgery in Tasmania; (ii) patients requiring revisional surgery used more hospital 
services than primary surgery recipients before and after their respective surgery; (iii) bariatric 
surgery planning in the public sector should make adequate provision for revisional surgery 
patients to account for their more frequent and prolonged hospital in-patient stays and increased 
rates of ED presentations. 
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Chapter 6: Discussion 
6.1 General discussion 
The conducted studies describe the influence of bariatric surgery on public hospital 
service use and, in particular, the impact of revisional bariatric surgery on public hospital 
admission rates and emergency department presentations in Tasmania. In addition to this 
analysis, different revisional surgery sequences were mapped, thus demonstrating the 
complexity of revisional bariatric surgery patient pathways. While providing some 
information, these studies also identified significant gaps in the current literature and policies 
that require further improvement and actions. While focusing on the laparoscopic adjustable 
gastric banding that was the predominant procedure in Tasmania during the study period, the 
results still have broader relevance, as we were also studying outcomes of those who were wait-
listed and did not receive an operation. Moreover, the results of the study might guide policy 
makers in the choice of procedure to be performed in the public setting. 
We did not find any decrease in public hospital service use rates for at least the first 
three years after bariatric surgery was conducted in Tasmania. This study did not explore the 
costs associated with public hospital service use. Moreover, costs are determined by not only 
the rates of service use but also the reasons for hospital admissions and emergency department 
presentations, which most likely changed after bariatric surgery. As discussed earlier, the 
possible changes in outpatient and primary care services use were not explored but can 
influence the total healthcare costs of bariatric patients. 
Although the costs were not explored, with the current state of high demand for public 
hospital beds and the significant strain on the public system in Tasmania, costs are not the only 
major factor for policy makers to consider. A recent report released by the Australasian College 
of Emergency Medicine highlighted the increased risk to patients due to difficulties in 
accommodating hospital inpatients (access block) and breaching emergency department 
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recommended assessment times. This problem is particularly evident in Tasmania, as well as 
in the Australian Capital Territory and South Australia [1].  
At the current time, due to the low numbers of bariatric procedures in the public sector, 
bariatric patients are not making a substantial contribution to the access block problem. This, 
however, may change with any future expansion of bariatric surgery provision. As discussed 
in Chapter 3, the likelihood of being admitted to hospital from the emergency department 
increases after bariatric surgery and can possibly explain the findings of a significant increase 
in hospital admission rates without a significant increase in emergency department presentation 
rates after bariatric surgery. 
One of the main conclusions of this study is that performing bariatric surgery in the 
public sector does not keep patients out of hospitals after primary surgery and does not decrease 
public health service use. Although bariatric surgery certainly provides many health benefits, 
it cannot be performed with the aim of reducing the demand for health services. In contrast, 
with the expanding provision of primary bariatric surgery, increasing demand is expected. As 
the recent Australian expert consensus on the treatment of obesity in the public sector stated, 
significant improvements are required in the provision of treatment for obesity, including 
establishing new services in areas of need and expanding the capacity of existing services [2], 
and we should expect increases in not only primary but also revisional bariatric surgery 
numbers. This outcome should be planned for pre-emptively, including by training surgeons to 
perform procedures complying with emerging policies and planning for increased admission 
and emergency department presentation rates in the short term and increased demand for 
revisional surgery in the medium and long terms. 
 Although the reasons for revisional surgery have been extensively investigated and 
include inadequate weight loss, weight recidivism (regain), or specific complications [3], the 
factors associated with inefficiency or even failure of secondary surgery requiring re-revision 
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remain under-investigated. A longitudinal study from Portugal focusing on the psychological 
aspects associated with revisional surgery found that eating patterns after primary bariatric 
surgery may represent a factor compromising the success of revisional surgery and leading to 
further re-revisions [4].  
Despite the absence of guidelines for revisional bariatric procedure choice, a recent 
survey of 460 bariatric surgeons from 62 countries revealed that there are certain trends in the 
revisional procedure sequence, with certain sequences favoured by the majority of the surgeons 
surveyed [5]. Roux-en-Y gastric bypass was the most favoured revisional option for all primary 
procedures. The majority of surgeons also incorporate allied health professional input in the 
management of revisional bariatric surgery patients. The survey also showed that 90% of 
bariatric surgeons consider demand in revisional surgery as mostly patient-driven despite 
funding by patient out-of-pocket expense in the practice of more than 50% of surgeons, with 
46% public funding and 32% insurance funding in the surveyed practices. Due to the nature of 
the study, those figures may not accurately represent funding sources for revisional bariatric 
surgery, but they still demonstrate the importance of revisional surgery for the public sector 
and the lack of private insurance funding, which therefore limits patient access to revisional 
surgery and places pressure on public systems. 
Although primary bariatric surgery lacks prioritisation guidelines, it has clear 
indications that allow the determination of the eligibility of a patient to receive a primary 
procedure in the public setting [6]. There are no clearly outlined indications for bariatric 
surgery, and moreover, there is no universally accepted grading of outcomes, with weight loss 
failure defined differently by different authors. A systematic review of definitions of failure in 
revisional surgery identified that the majority of studies do not define failure at all, and others 
use <50% or <25% of excess weight loss as cut-off points [7]. Weight regain also lacks a 
uniform definition [8], and applying different definitions for weight regain following sleeve 
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gastrectomy to the same retrospective cohort resulted in regain rates ranging from 9 to 91 % 
[9]. Therefore, the introduction of a universally accepted definition of failure and weight 
recidivism in bariatric surgery should be one of the first steps in revisional guideline 
development. This step would allow the evaluation of the efficiency of publicly run bariatric 
programs, the identification of patients who might benefit from treatment escalation, and the 
selection of patients who can be offered treatment escalation in the public system if it is 
accessible. However, privately funded surgery may have different drivers for revisions, with 
providers or patients seeking earlier escalation of treatment, which would reduce the influence 
of any new guidelines. 
This study identified the significant impact of revisional bariatric surgery on hospital 
service use in public healthcare, and further policy implications are required to regulate this 
largely overlooked area of bariatric surgery. There are possible options for policy applications 
depending on the outcome expected. 
Given that revisional surgery in the public sector has shorter wait-list times and is 
associated with significantly lower drop-out rates compared with primary surgery, resulting in 
lower access to primary surgery for eligible patients, one of the simpler options is to separate 
the primary and revisional streams and create two independent wait-lists. Further development 
of this policy would consist of introducing prioritisation guidelines for both primary and 
revisional surgery. 
Given the length of re-revisional pathways identified in our studies and the established 
demand for re-revisional bariatric surgery, one policy option to prevent tertiary and further 
procedures in the public sector could be a One Revision Policy of performing reversal 
procedures only. Removal of a gastric band is a technically safe procedure; however, patients 
are guaranteed to experience weight regain [10]. Reversals of Roux-en-Y gastric bypass are 
described in the literature as a feasible procedure; however, they are associated with significant 
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morbidity [11, 12]. Another option would be to limit revisions only to patients with 
complications of bariatric surgery and not to perform revisions for insufficient weight loss or 
weight regain. The possible drawback of this policy is that it could result in placing a label of 
“treatment failure” on a significant number of patients without providing further effective 
treatment options in the public sector. There is also evidence that for certain categories of 
patients, such as those with refractory metabolic disease, revisions for inadequate weight loss 
or weight regain remain beneficial [13, 14]. The reasons for revisions in the public sector were 
not explored in this study and should be addressed in future research, as the impact of a policy 
limiting access to revisional surgery has not been explored. Such a policy will, however, 
contradict the currently accepted paradigm of treatment escalation and will differentiate 
bariatric patients from patients receiving other types of surgeries where revisions are common, 
such as coronary artery bypass grafting or total joint arthroplasty [15]. 
Another way to reduce the number of revisions in the public sector is to stop providing 
surgeries resulting in high numbers of revisions in the public sector. For example, in a recent 
study of more than 19,000 patients in the state of New York, the revisional rate for laparoscopic 
adjustable gastric banding (LAGB) resulted in revision rates of up to 34% during a 7-year 
period [16]. In a meta-analysis including 2,280 patients with sleeve gastrectomy with more 
than 7 years of follow-up, the overall revision rate was estimated to be up to 20%, with an 
estimated long-term weight recidivism rate of 28% [17]. It is not clear whether Roux-en-Y 
gastric bypass or single anastomosis gastric bypass is preferable in terms of revisional rates 
[18]. The United States national database study showed that insurance status influences the 
choice of primary bariatric surgery, with a larger proportion of LAGB recipients uninsured or 
having Medicare coverage compared with other types of bariatric surgery. Having a managed 
care insurance plan was a strong predictor of sleeve gastrectomy as a primary procedure [19]. 
Similarly, in Australian hospitals in 2014–2015, the proportion of LAGB performed in public 
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hospitals was higher than in the private sector [20]. Therefore, the high revisional rates post-
LAGB and high morbidity following its revisions, along with the high re-revisional rates 
identified in our systematic review, might discourage providers from offering LAGB as a 
primary or revisional bariatric procedure in a public system with the aim of reducing revisional 
burden. 
Given the high numbers of patients who have already had LAGB and the continued use 
of this surgery in the private system, this measure will not have an immediate result. However, 
it is expected to contain the increase in revisional surgery numbers. The option of restricting 
access to LAGB in the private system can also be explored, such as by modifying guidelines, 
consensuses and bariatric society position statements to discourage LAGB as a primary 
procedure.  
Surgeons should also be educated on policy implications as they may change their 
approach to patients with different insurance status and different insurance coverage. At the 
extreme, access for private patients self-funding their bariatric surgery could be limited if they 
are not able to afford further revisions. 
Preoperative patient education can improve weight loss outcomes and reduce 
readmission rates [21, 22]. A qualitative study showed that patients can have unrealistic 
expectations about bariatric surgery, which lead to seeking revisions when these expectations 
were not met [23]. Therefore, patients should be educated on the expected outcomes and 
likelihood of revisional surgery, including the possibility of further re-revisions. This education 
also should include education on insurance implications, and self-funding or taking insurance 
only for a short time to be dropped after bariatric surgery should be discouraged. 
This step might require additional actions from another player in the field – insurance 
companies – by providing extended coverage for bariatric procedures, such as covering all 
subsequent revisions required as part of treatment or reversals only, as discussed above. This 
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extended coverage could take the form of an enforced policy or be used by insurers to create 
more attractive insurance plans. Moreover, this coverage could drive insurers to pay only for 
more effective surgeries with lower revisional rates and not fund revision-prone primary 
procedures or revisional surgeries with high re-revision rates, as well as limiting co-operation 
with bariatric centres with less-favourable outcomes. Some insurance companies in the United 
Stated have imposed conditions such as compliance with preoperative programs and mandatory 
preoperative weight loss [24, 25], and these mandatory requirements could be extended.  
A key to the development of these policies and adjusting them for the greatest efficiency 
is long-term follow-up of all bariatric patients, private and public, and thorough capture of all 
outcomes. This follow-up is usually accomplished using bariatric registries, which are 
especially important for bariatric surgery for quality assurance and the development of 
strategies based on large-volume datasets applied to particular healthcare systems [26, 27]. 
The nationwide use of registries could also address the problem of not being able to 
follow-up due to interstate patient movements, as we were informed that some of the revisions 
for Tasmanian primary bariatric surgeries were performed interstate and therefore were not 
reflected in our studies. Without control of such outcomes, states might actually be interested 
in limiting interstate bariatric surgery transfer to optimise their policies in the setting of 
different policies applied at the state and national levels [28]. Moreover, if different 
access/outcome patterns emerge in long-term follow-up, this can justify differences in policy 
approaches, and vice versa, leading to standardisation if optimal pathways are found. 
Future research should be prospective and capture a longer period of patient follow-up. 
It should focus on patient selection for primary bariatric surgery and wait-list prioritisation 
strategies and determine predictors of drop-out from wait-lists to optimise bariatric surgery 
delivery to patients who will benefit the most. Additionally, this will allow for better 
management of wait-lists and public healthcare service demands.  
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